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ABSTRACT 
 
Epilepsy is one of the most common neurological disorder worldwide and about 30% of 
diagnosed patients are pharmacoresistant. For some of these, the most efficient treatment 
is resective surgery, which surgically removes the epileptogenic zone (EZ). However, this 
surgery is challenging in patients with cryptogenic focal epilepsy (cFE), when conventional 
MRI fails to localize the EZ.  
The purpose of this project was to establish a novel diagnostic method to localize the EZ in 
patients with pharmacoresistant cFE using diffusion tensor imaging (DTI). The main 
hypothesis was that the short association fibers, called U-fibers, located directly at the grey 
and white matter junction are affected in epilepsy by a common pathology called focal 
cortical dysplasia, which is often not seen in conventional MRI.  
This thesis entailed different steps in the development of the method, starting with a pilot 
version of the method where U-fiber track density images (ufTDI) were quantified for 
patients with cFE using a small number of healthy controls and default settings of the used 
software. The remaining part of the thesis involved optimizing and improving the method 
to increase the sensitivity and specificity.   
This novel diagnostic method is now a valuable tool in patients considered for resective 
epilepsy surgery. It is already routinely used at the Epilepsy Centre at the University of 
Munich Hospital, as a guidance tool for implantation of the electrodes for invasive EEG 
recordings.  
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DTI: Diffusion Tensor Imaging 
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FCD: Focal Cortical Dysplasia 
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MRI: Magnetic Resonance Imaging 
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SPECT: Single-Photon Emission Computed Tomography 
SPM: Statistical Parametric Mapping 
SPMd: SPM default 
SPMo: SPM optimised 
TDI: Track Density Images
Chapter 1. Introduction   1 
           
 
CHAPTER 1. INTRODUCTION 
1.1. EPILEPSY 
Epilepsy, characterized by recurrent seizures, is one of the most common 
neurological disorder affecting ~1% of population worldwide. It can be treated with 
antiepileptic drugs (AEDs), but ~30% of patients have pharmacoresistant epilepsy, which is 
diagnosed after a failure of at least two AEDs treatments. In many of these cases, resective 
surgery is an alternative treatment, where the source of the focal epilepsy is removed.  
The success of resective surgery, measured by seizure freedom, depends on different 
prognostic factors e.g. presence of detectable lesions, scope of the resection, underlying 
pathology, the localization of the epileptogenic zone (EZ) and the surrounding brain 
structures (McIntosh et al., 2012; Ramey et al., 2013). However, seizure freedom is achieved 
in only 49.8% of extratemporal lobe epilepsy (Ramey et al., 2013), possibly due to partial 
resection or incorrect estimation of the extent of the EZ.  
Epilepsy can be secondary to various detectable lesions, such as tumors, vascular 
malformation, ischemic changes or cortical dysplasia. Therefore, pre-surgical evaluation 
and planning of the resection is greatly dependent on neuroimaging techniques (McIntosh 
et al., 2012). However, up to 50% of patients with focal epilepsy do not have a visible lesion 
in a conventional MRI and therefore are diagnosed with cryptogenic focal epilepsy (cFE). 
This makes the surgical outcome harder to predict due to limited pre-surgical outlining of 
the region that needs to be resected (Ramey et al., 2013). 
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1.1.1. SIX CORTICAL ZONES IN FOCAL EPILEPSY 
Apart from the epileptogenic lesion, six cortical zones are defined to aid in the pre-
surgical evaluation (Lüders, 2008): seizure onset zone, irritative zone, symptomatogenic 
zone, epileptogenic zone, functional deficit zone and eloquent cortex. The spatial extent of 
the zones varies. They can be regional, lateralized, non-lateralized, bilateral or bilateral with 
asymmetrical seizure evolution. This can have a great impact on the surgery planning and 
its outcome. 
The epileptogenic lesion is a radiographic lesion that can be seen in magnetic 
resonance imaging (MRI) or computed tomography (CT) and causes epileptic seizures. In 
cryptogenic epilepsy, the epileptogenic lesion is not visible. Naturally, not all radiographic 
lesions are epileptogenic, therefore they have to be cautiously verified using different 
diagnostic tools. The relation to EZ is similar to the seizure onset zone, where a complete 
resection of the lesion does not necessarily result in seizure freedom. This could be the case 
if the lesion is not intrinsically epileptogenic, but can induce seizures by causing reactions 
in the surrounding tissue. Another explanation could be an incomplete detection of the 
extent of the lesion, e.g. the tissue surrounding the lesion have a more subtle or diffuse 
pathology and thus not be detected by MRI. This is frequently the case with focal cortical 
dysplasia.  
The seizure onset zone is an area of the cortex that generates clinical seizures and is 
typically localized using scalp or invasive electroencephalogram (EEG) methods, like depth 
or subdural electrodes to detect the electrical activity representing an epileptic seizure, as 
well as ictal single-photon emission computed tomography (SPECT), which can identify a 
regional increase in blood flow in response to the high metabolic demand of an epileptic 
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seizure. Unlike the irritative zone, the seizure onset zone generates repetitive discharges 
that are strong enough to generate clinical ictal symptoms. However, this cannot be 
confused with the EZ. Often the EZ is more extensive than the seizure onset zone indicating 
that a complete resection of the seizure onset zone alone will not result in seizure freedom, 
if some of the EZ remains unresected. This happens when the seizure onset zone has 
multiple thresholds within a single EZ. Only the seizure zone of the lowest threshold is 
detected prior to surgery, therefore another seizure onset zone with a higher threshold may 
become clinically visible after the resection of the previous zone. Occasionally, the seizure 
onset zone is larger than EZ and partial resection of the seizure onset zone can still lead to 
seizure freedom if the entire EZ was resected. 
The irritative zone is an area of the cortex that produces interictal spikes (also called 
interictal epileptiform discharge), measured by scalp EEG. Interictal spikes are short 
(<250ms) events observed in EEG that occur between seizures and usually isolated and 
independent spikes will not produce any clinical symptoms. The presence of interictal 
spikes strongly supports the diagnosis of epilepsy.  
The symptomatogenic zone is an area of the cortex, which produces ictal symptoms 
during a seizure. It is common for this zone to reach beyond the EZ, because seizures are 
dynamic events, propagating through the brain over time. Some parts of the brain, when 
electrically stimulated are silent, i.e. a focal seizure in this area would not cause visible 
clinical symptoms. During a seizure, occasionally symptoms are generated only when the 
electrical activity spreads to adjacent eloquent cortex. 
The epileptogenic zone (EZ) is defined as the area of the cortex that is indispensable 
for the generation of epileptic seizures and whose resection is necessary and sufficient for 
seizure control in pharmacoresistant focal epilepsy. Unfortunately, there is currently no 
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diagnostic modality that can measure the EZ directly. Therefore, the location of the zone 
must be measured indirectly, by defining the above-mentioned zones. 
It has been suggested, that in some cases, the EZ is not bound to only one region, but 
is interconnected to other regions (Buser and Bancausd, 1983). One example is the 
corticocortical facilitatory connections, which describe fronto-temporal epilepsy (Bancaud 
and Talairach, 1992). 
The functional deficit zone is defined as regions of the cortex, which are functionally 
abnormal during the interictal period. The spatial extent of the functional deficit zone 
usually reaches beyond the EZ and can be investigated directly with neurological 
examination, neuropsychological assessment and indirectly with EEG, SPECT and PET. 
Generally, the functional deficit zone can only lateralize and estimate the localization of the 
EZ to the lobe affected in focal epilepsy, but is not specific. However, it does provide 
complementary information to the other five zones during the pre-surgical evaluation.  
The eloquent cortex is cortex that carries a specific, relevant function and must be 
spared during surgery. The aim of the surgery is to resect the complete EZ with good 
boundaries, but at the same time sparing the eloquent cortex in order to avoid additional 
deficit for the patient. To identify eloquent areas, the cortex can be electrically stimulated to 
test whether this results in a functional impairment or not. However, in situations where 
the eloquent cortex overlaps with the EZ, sparing of the eloquent cortex has the priority and 
would only allow partial resection of the EZ with lower chances for post-surgical seizure 
freedom. If a patient is a candidate for surgery, then the individual risk factors have to be 
discussed with the patient prior to the resection. 
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1.1.2. PATHOLOGY 
Focal epilepsy can be caused by different underlying pathologies and the 
consequences of seizures on the brain are complex affecting both brain function and 
structure. The structural alterations are present at different levels, such as cellular, synaptic 
and molecular, some of which may be permanent (Thom, 2011). To achieve seizure 
freedom in pharmacoresistant focal epilepsy, the EZ must be resected using a number of 
diagnostic tools to outline the borders of the EZ (see Section 1.1.3).  
The histopathology of resected tissue in cFE often shows malformations of cortical 
development (MCD), which is an outcome of abnormal prenatal development of the brain. 
The pathology involves neuronal proliferation, migration and organization of the cerebral 
cortex. MCD occurs in cFE, however, focal cortical dysplasia (FCD) is a more frequent 
pathology, especially in pharmacoresistant focal epilepsy (Blümcke et al., 2011).  
FCD includes a wide spectrum of abnormalities in the grey and white matter and is 
characterized by the occurrence of histological abnormalities of the organization of the 
cortex, blurring of the grey and white matter border, dysmorphic neurons, balloon cells and 
ectopic neurons in the subcortical white matter (Besson et al., 2008; Blümcke et al., 2011). 
FCD can be diffuse or focal and can vary in severity. More severe forms of FCD can typically 
be detectable in MRI scans (Figure 1).  
FCD has a wide spectrum of characteristics and often it is difficult to reach a 
consensus for the classification of the histopathological specimen amongst 
neuropathologists (Chamberlain et al., 2009). Currently FCD can be classified into Type I 
and Type II, and recently Type III has been proposed (Blümcke et al., 2011).  
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Type I subdivides into Type IA and IB. Type IA shows architectural alterations of the 
cortical lamination, whereas Type IB additionally includes hypertrophic pyramidal neurons. 
Type II FCD can also be subdivided into IIA and IIB types of pathology. The hallmark of FCD 
Type IIA are dysmorphic neurons and Type IIB also includes balloon cells.  
The pathology can be located anywhere in the cortex and the extent of the pathology 
varies. Some types of FCD are more frequent in certain regions of the brain than others, e.g. 
FCD Type II is more commonly occurring in extratemporal areas, particularly in the frontal 
lobe (Blümcke et al., 2011).  
Neuroimaging techniques have been used extensively for diagnosing FCD. However, 
it has been proven to be limited. Neuroimaging is not able to reliably identify the FCD 
subtypes and often cannot detect subtle forms of FCD or the total extent of the pathology, 
making the delineation more difficult. Additionally, often patients diagnosed with the same 
FCD subtype according to Palmini’s classification system show different imaging 
characteristics (Lerner et al., 2009). 
The histopathology of the resective tissue in cryptogenic focal epilepsy often shows 
mild MCD (mMCD), which entails subtler end of the spectrum of cortical abnormalities than 
MCD or FCD and are often referred to as mild architectural changes (Lüders, 2008; Thom, 
2011), such as blurring of the grey and white matter border and excess of cortical neuronal 
clusters. The diagnosis of mMCD is a challenging one, as there is no established 
immunohistochemical method that labels the ‘ectopic’ neurons from the normal neuronal 
population. This of course leads to less consensus on the diagnosis of mMCD compared to 
other, more severe forms of FCD (Thom, 2011).  
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1.1.3. PRE-SURGICAL EVALUATION 
An extensive diagnostic investigation is needed to determine whether a patient with 
pharmacoresistant focal epilepsy is a candidate to undergo resective surgery. The aim of 
such a surgery is to remove the EZ, while sparing the eloquent cortex. To achieve this, 
several diagnostic tools are used, like scalp EEG with video monitoring, MRI, Positron 
Emission Tomography (PET) and SPECT (Rosenow and Lüders, 2001).  
Typically, T1-, T2-weighted and FLAIR sequences are used for basic MRI evaluation. 
FLAIR sequences are particularly successful for localizing the epileptogenic lesions (Figure 
1). On the other hand, T1 and T2-weighted sequences can show the blurring of the grey and 
white matter border, which is characteristic of FCD.  
 
Figure 1 Epileptogenic lesion seen in T2 and T2-FLAIR. At the Epilepsy Centre, patients routinely obtain 
neuroimages including A) T1 showing blurred grey and white matter junction B) T2 showing cortical 
thickening and C) T2-FLAIR, where the signal is enhanced around the epileptogenic lesion. Curtesy of Dr. 
Christian Vollmar. 
 
Scalp EEG is another important diagnostic tool, essential in the pre-surgical 
evaluation of epilepsy. It measures the electrical activity of the brain and is able to lateralize 
and localize the seizure onset zone in majority of cases. Currently, video-EEG monitoring is 
the gold standard for defining the irritative and seizure onset zones (see Section 1.1.1) 
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when recording a sufficient amount of ictal and interictal EEG (Lüders, 2008; Rosenow and 
Lüders, 2001).  
One limitation of scalp EEG is low sensitivity to deep cortical areas, such as mesial 
frontal or fronto-orbital regions, due to the large distances between the scalp electrodes 
and those cortical areas. Usually, scalp electrodes are only able to detect the discharges 
after they have spread considerably. Scalp EEG is typically combined with video monitoring 
to assess the seizure semiology.  
Seizure semiology allows for the localization of the symptomatogenic zone, which is 
usually in close proximity to the epileptogenic zone. Thereby seizure semiology contributes 
localizing information to the pre-surgical evaluation and can be particularly helpful in cFE. 
There are several established lateralizing and localizing signs of auras and seizures 
(described in detail in Lüders et al., 1999; Tufenkjian and Lüders, 2012) and some of these 
signs have a correct lateralization rate of > 95%. For example, clonic movement of the left 
hand indicates an epileptic activation of the right precentral cortex. If this occurs early in 
the seizure, chances are high that the epileptogenic zone is in close proximity to the right 
motor cortex. 
If scalp EEG and seizure semiology do not allow for the exact localization or 
lateralization of the seizure onset zone, then additional methods are needed, including 
intracranial EEG recording, such as depth or subdural electrodes. Information obtained 
from scalp EEG and MRI guides the implantation of intracranial EEG recording. Even though 
the pre-surgical evaluation for the resection relies mainly on intracranial EEG for 
delineating the EZ (Rosenow and Lüders, 2001; Zhang et al., 2014), it is crucial to have a 
strong clinical hypothesis for the location of the EZ, when planning the implantation of the 
depth electrodes. This is because depth electrodes record activity from a very localized and 
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limited region and the total number of electrodes that can be implanted is limited. However, 
they are highly sensitive due to the direct contact with the brain matter and accurately 
record the epileptic activity. On the other hand, the subdural grid is more invasive than 
depth electrodes and has higher risk of complications, but it covers a larger area of the 
cortex, which can be beneficial when the location of the EZ is not clear (Zhang et al., 2014).  
Another important diagnostic test is the ictal SPECT, which is based on cerebral 
metabolic and perfusion coupling. During a seizure, neurons are hyperactive resulting in an 
increased metabolic demand and a regional increase in blood flow. This ictal 
hyperperfusion can be depicted with a SPECT scan, if the tracer is injected early during the 
seizure, preferably within 20 seconds after the seizure onset (Van Paesschen, 2004). The 
evaluation of ictal and interictal SPECT can be challenging. The sensitivity of SPECT in 
localizing the EZ increases when computer-aided subtraction ictal SPECT co-registered to 
MRI (SISCOM) is applied (O’Brien et al., 1998).  
Another nuclear medicine technique, called positron emission tomography (PET), 
often can reliably identify dysfunctional cortex with hypometabolism. It is often acquired in 
cFE and in some cases the EZ can be visible because of a change in glucose metabolism in 
the affected region of the brain reflecting the regions of functional deficit (Lüders, 2008). 
 All of the above mentioned methods reflect different aspects of the epileptogenic 
network and provide complementary information when combined, thus increasing the 
sensitivity and specificity of the diagnosis. The need to use all of the methods show how 
complex the pre-surgical evaluation of focal epilepsy is. This process becomes even more 
challenging in cFE.   
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1.1.4. CRYPTOGENIC FOCAL EPILEPSY 
Cryptogenic, or MRI-negative, focal epilepsy is a classification of epilepsy where the 
lesion is not visible in conventional MRI. The diagnostic protocol remains the same as for 
lesional focal epilepsy. The only difference is that there is no visible lesion in MRI, which 
would be a valuable clue, where to look first. In cFE, the diagnosis relies almost exclusively 
on EEG, semiology and nuclear medicine like SPECT and PET.  
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1.2. DIFFUSION MRI 
Diffusion weighted MRI is a specific MRI acquisition that allows for the 
quantification of water diffusion in tissue. The process of diffusion is influenced by the 
structure of the tissue, like cell membranes, cytoskeleton and macromolecules (Le Bihan, 
2014). This enables indirect inferences on the cellular integrity and pathology of the tissue. 
The diffusivity depends on the angle between the fiber track and the applied magnetic field 
gradient. The diffusivity is largest when the magnetic field gradient is parallel to the fiber 
direction and smallest when it is perpendicular (Basser et al., 1994). Application of 
gradients to enhance the diffusion attenuation introduces a contrast mechanism creating 
diffusion-weighted images (DWI).  
In grey matter, the measured diffusivity is mainly isotropic, i.e. uniform in all 
directions. Therefore, the diffusion characteristics can be measured using a single apparent 
diffusion coefficient (ADC). However, white matter tissue is anisotropic, where the 
diffusivity is dependent upon the orientation of the axonal bundles and a single ADC is not 
sufficient (Basser et al., 1994). A more complex model has to be applied in order to account 
for the anisotropic properties of the axonal bundles by implementing a diffusion tensor of 
water.   
 
1.2.1. DIFFUSION TENSOR IMAGING 
A tensor is a 33 matrix representing the orientation of the anisotropic diffusion 
with respect to the three orthogonal axes of the reference frame (Stejskal and Tanner, 
1965). Diffusion tensor imaging (DTI) is a technique measuring the diffusion tensor from 
each voxel in the brain (Basser et al., 1994). This allows for the calculation of diffusivity 
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(degree of diffusion), anisotropy (directionality of the diffusion) and principal direction, 
therefore providing information on the microstructure of the tissue and white matter tracts 
that cannot be obtained in standard MRI.  
There are two main DTI-based scalars: fractional anisotropy (FA) and mean 
diffusivity (MD). FA shows the degree of directionality of water diffusion, where a high FA 
indicates a diffusion restriction along one direction, and low FA indicates unconstrained 
diffusion equally in different directions. MD on the other hand shows the total degree of 
diffusivity, regardless of the directionality. In the vicinity of a lesion, FA is often decreased 
and MD increased (Dumas de la Roque et al., 2005). Even though both of these measures, FA 
and MD, have shown alterations in many neurological diseases, in focal epilepsy these 
changes often remain non-specific (Winston, 2015). 
 
1.2.2. TRACTOGRAPHY 
Tractography is currently the only available tool for identifying white matter 
pathways non-invasively and in vivo in humans. It is based on the fundamental assumption 
that when axons align along a common axis, the diffusion of water is greater along than 
across the axis (Behrens et al., 2003). Tractography is a process of integrating voxel-wise 
fiber orientations into a pathway (Behrens et al., 2009) by streamlining through a vector 
field. The streamlines can be reconstructed at any starting seed by following the main 
direction of water diffusion (Figure 2), it moves on to the next vector and so on until it 
reaches the stopping vector. Streamline tractography has many advantages, including fast 
reconstruction of fibers, does not require special computational equipment or training and 
is able to reconstruct many major white matter tracts.  
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Figure 2 Streamline tractography. The blue line represents the streamline that follows the orientation of 
the diffusion. Image was created by the author of this thesis. 
 
Although streamline tractography allows for non-invasive research, it can be prone 
to errors. One key limitation of diffusion tensor model is that it can only recognize a single 
fiber orientation in each voxel. Therefore, the model might fail at locations with crossing or 
kissing fibers. There are multiple alternative models and algorithms that recover more 
information about the fiber orientation from a single voxel, such as high angular resolution 
diffusion imaging (HARDI) (Tuch et al., 2002), QBall imaging (Tuch, 2004) or constrained 
spherical deconvolution (CSD) (Anderson and Ding, 2002), which can be helpful to 
delineate a more complex topography in regions with crossing fibers.   
 
1.2.3. DTI IN EPILEPSY 
Alterations related to pathology like FCD and MCD (see Section 1.1.2) have been 
described in DTI, mainly by reduced anisotropy and increased diffusivity within the 
proximity of the EZ in patients with MRI-visible FCD (Dumas de la Roque et al., 2005; 
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Eriksson et al., 2001). In some patients, the extent of the alterations exceeded beyond the 
borders of MCD visible on conventional T1- and T2-weighted images (Eriksson et al., 2001).  
Diffusion Tensor Tractography (DTT) has been shown to detect structural changes in 
cFE (Vollmar and Diehl, 2011), where the number of tracts was reduced in the 
epileptogenic zone compared to the healthy contralateral side.  
The specificity of DTI in localizing the EZ is higher for extratemporal than temporal 
lobe epilepsy (Thivard et al., 2006), possibly due to the higher prevalence of dysplastic 
lesions in extratemporal epilepsy, as opposed to hippocampal sclerosis in temporal 
epilepsy. Thivard et al (2006) also suggested that the epileptic networks associated with 
extratemporal and temporal epilepsy differ in structural connections and cytoarchitecture.  
   
  
Chapter 1. Introduction   15 
           
 
1.3. AIMS OF THE THESIS 
The aim of this PhD thesis is to establish a new diagnostic method that localizes the 
epileptogenic zone in patients with pharmacoresistant cryptogenic focal epilepsy (cFE) by 
quantifying the density of short association fibers, called U-fibers, obtained through DTI. 
The main objectives are: 
1. To compare the sensitivity and specificity of the conventional DTI-based measures FA 
and MD with track density images (TDI), including whole brain TDI and U-fiber TDI, for 
the detection of the epileptogenic zone in individual patients with cFE.  
2. To compare the results of the method to the electroclinical data obtained from the 
hospital. 
3. To compare different options throughout the pre-processing pipeline, to optimize the 
pre-processing steps of the method. 
4. To investigate the effects of the control population on the results of the quantification.  
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CHAPTER 2. FROM FA TO U-FIBERS 
2.1. CONTRIBUTIONS 
 
The work was done under the supervision of Dr. Christian Vollmar (CV). Joanna Goc (JG) 
and CV designed the research. JG, CV and Dr. Elisabeth Hartl (EH) recruited and scanned 
participants. JG designed the method and carried out the research and analysis and together 
with CV discussed the results. JG wrote the article. 
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Abstract  
Pharmacoresistant focal epilepsy may be treated surgically by removing the 
epileptogenic zone (EZ). However, in patients with cryptogenic epilepsy no structural lesion 
is visible in clinical MRI, challenging the localization of the EZ and planning of the resective 
surgery. Here, we show a DTI analysis approach based on a quantification of regional track 
density images (TDI) and compare that to conventional FA and MD maps to localize 
previously undetected structural abnormalities in the EZ.  
Ten patients with MRI-negative focal epilepsy with clear clinical localization of the 
EZ were compared against 42 controls. DTI data was acquired on a 3T GE Signa HDx 
Scanner with 64 diffusion-weighted directions and b-value of 1000 s/mm². DTI data was 
processed and FA and MD maps were created. Whole brain streamline tracking was 
performed and three TDI were created. These track density images were spatially 
normalized together with FA and MD to a common template space. Statistical comparison to 
the healthy control population was carried out to identify alterations in individual patients. 
The resulting significant alterations were compared to clinical data. 
All DTI-based measures showed alterations in patients with epilepsy, beyond the 
range seen in healthy controls. However, the extent and specificity of these alterations 
varied. The quantification of U-fiber track density images correctly identified the EZ in 80% 
of the patients, compared to only 20% and 10% for FA and MD, respectively, showing that 
these frequently used DTI measures are not ideal to localize specific alterations in the EZ.    
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Abbreviations: DTI = diffusion tensor imaging; MRI = magnetic resonance imaging; PET = 
positron emission tomography; SPECT = single-photon emission computed tomography; 
SPM = statistical parametric mapping; CVA = conventional visual analysis; cFE = 
cryptogenic focal epilepsy; HP = healthy population; CTR = control; FA = fractional 
anisotropy; MD = mean diffusivity; TDI = fiber density image; EZ = epileptogenic zone 
 
  
Chapter 2. From FA to U-Fibers   20 
           
 
1. Introduction 
Epilepsy is one of the most commonly occurring neurological diseases affecting up to 
1% of the population and is typically treated with medication. However, according to World 
Health Organization (WHO, 2016), 30% of patients do not respond sufficiently to 
medication (pharmacoresistant epilepsy) and for some of these patients resective epilepsy 
surgery might be an effective treatment option (Rosenow and Lüders, 2001). Up to half of 
the candidates for epilepsy surgery have non-lesional, “cryptogenic” focal epilepsy (cFE), 
where conventional MRI does not show underlying structural lesions and the localization of 
the epileptogenic zone (EZ) depends on complementary diagnostic methods. The success 
rate of resective surgery in cryptogenic epilepsy (measured by the absence of seizures) is 
often lower than in lesional epilepsy (Martin et al., 2015). The outcome of surgery depends 
on multiple factors, starting from the type of underlying histopathology (Yao et al., 2014) to 
correct localization and complete resection of the EZ, which is not straight forward in MRI-
negative patients.  
One of the most frequent causes of focal drug-resistant epilepsy is focal cortical 
dysplasia (FCD), a structural pathology characterized by histological abnormalities of the 
laminar layers of the cortex, blurring of the white and grey matter border, dysmorphic 
neurons, balloon cells and ectopic neurons in the subcortical white matter (Besson et al., 
2008; Blümcke et al., 2011). More severe forms of FCD are detectable with conventional 
MRI and occasionally with diffusion tensor imaging (DTI) (Dumas de la Roque et al., 2005; 
Eriksson et al., 2001; Rugg-Gunn et al., 2001; Widjaja et al., 2011). However, mild 
malformations of the cortical development (MCD) are often missed even with an optimized 
epilepsy MRI protocol.  
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In recent years, DTI has become more popular in clinical diagnostics. Most 
commonly used DTI-derived scalars include: fractional anisotropy (FA) and mean 
diffusivity (MD). FA shows the degree of directionality of water diffusion, where a high FA 
indicates a diffusion restriction along one direction, and low FA indicates unconstrained 
diffusion in different directions. MD on the other hand shows the total degree of diffusivity, 
regardless of the directionality. In the vicinity of a lesion, FA is often decreased and MD 
increased (Dumas de la Roque et al., 2005; Eriksson et al., 2001; Rugg-Gunn et al., 2001). 
Even though both of these measures, FA and MD, have shown alterations in many 
neurological diseases, in focal epilepsy, these changes often remain non-specific (Winston, 
2015).  
An alternative DTI-based measure to FA or MD is track density imaging (TDI) 
(Calamante et al., 2015, 2010), a tractography mapping technique that has already been 
applied in various neurological disorders. The TDI maps are typically based on whole brain 
streamline tracking and represent the number of streamlines passing through any voxel.  
The possible microstructural alterations in cFE, like the blurring of the white and 
grey matter border could have an effect on fibers that are located in the proximity of the 
white-grey matter border, like on local short association fibers, called the U-fibers 
(Colombo et al., 2003). These microstructural changes might affect the tracking enough to 
yield a more specific effect than FA or MD. Thus, using alternative DTI-based measures 
based on fiber-tracking, like TDI, could improve the identification of subtle structural 
alterations in cFE. 
In this study we compared sensitivity and specificity of the conventional DTI 
measures FA and MD with different types of track density images (TDI) including a specific 
TDI for U-fibers only, for mapping the EZ in individual patients with cFE.  
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2. Methods and Participants 
2.1. Participants 
A group of 10 patients diagnosed with drug-resistant, cryptogenic focal epilepsy 
(cFE) [mean age of 30 years (SD: 9.9), 8 males] was investigated. All patients had 
conventional structural MRI at 3T using a specific epilepsy protocol, including high 
resolution 3D T1 and 3D FLAIR images, coronal FLAIR T2 and inversion recovery T1 
images, not showing any structural epileptogenic lesions. All patients underwent a series of 
neurological examinations including routine EEG and non-invasive EEG-video-monitoring, 
FDG-PET, SPECT and in most cases invasive intracranial EEG (n=8). All patients had a clear 
clinical hypothesis as for the localization of the EZ based on the conclusive interpretation of 
the aforementioned tests: bilateral frontal (n=1), right frontal (n=1), left frontal (n=4), right 
temporal (n=2), left temporal (n=1) and right parietal (n=1).  
A healthy population (HP) of 42 participants with no history of neurological or 
psychiatric disease [mean age of 29.4 years (SD: 6.1), 27 males] was scanned for 
comparison.  
Additionally, 10 controls (CTR) were individually compared to the HP group using 
identical procedures as for the cFE patients.  
The University of Munich Ethics Committee approved the study and all participants 
gave written and informed consent.  
 
2.2. DTI acquisition 
All participants had additional DTI data acquisition on a 3T GE Signa HDx Scanner 
using a DTI-acquisition scheme with 64 diffusion-weighted directions, a b-value of 1000 
s/mm², 60 axial slices with 2.4 mm slice thickness, a 96x96 in-plane matrix with a 220mm 
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field of view, TR 16000 ms, TE 90.2 ms, flip angle 90° and parallel imaging with a SENSE 
factor 2.  
 
2.3. DTI Processing  
The processing of DTI data involved several steps. Firstly, the images were 
resampled to isotropic 1mm voxel size and corrected for movement and distortions 
artefacts caused by eddy currents using FMRIB Software Library Version 4.1.6 (FSL; 
http://fsl.fmrib.ox.ac.uk). The diffusion weighted images were skull-stripped using the 
Brain Extraction Tool implemented in FSL. Next, using FSL dtifit, we created the two most 
commonly used DTI-based scalars: fractional anisotropy (FA) and mean diffusivity (MD). 
 
2.4. Streamline Tractography 
Deterministic streamline tracking was performed using the Diffusion Toolkit 
(http://trackvis.org/blog/tag/diffusion-toolkit/) seeding from every voxel within the brain. 
Tracking used a 2nd-order Runge Kutta propagation algorithm with an angular threshold of 
<35° between neighboring voxels. The termination criteria of the tracking were either 
exiting the brain or reaching a voxel with an FA value <0.1. The average whole brain track 
counts for cFE and HP were 979461 and 1034048, respectively. Visual quality check of the 
streamlines was performed using TrackVis (http://trackvis.org/). 
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2.5. Track-density imaging (TDI) 
The population of U-fibers was selected from the whole brain streamline data using 
the following selection parameters: length 20-60mm, curvature 2-10 and a U-factor, 
describing the shape of a fiber between 0.6-1.  
Using TrackVis, three types of track density images (TDI) were created: 1) whole 
brain TDI (wbTDI), 2) enhanced whole brain TDI (ewbTDI) and U-fiber TDI (ufTDI). To 
account for the underrepresentation of peripheral curved U-fibers in comparison to major 
deep white matter tracts (Girard et al., 2014) we created the ewbTDI map. It combines the 
wbTDI and the ufTDI multiplied by a factor of 5 to enhance the fiber density at the 
periphery of the dataset. In each density map, every voxel represents the number of fibers 
passing through it. 
 
2.6. Spatial Normalization 
The FA map was spatially normalized to the FMRIB58_FA template in MNI space 
using SPM5 software (http://www.fil.ion.ucl.ac.uk/) with the following settings: Source 
Image Smoothing 5mm FWHM, Non-linear Frequency cut-off 12mm, non-linear 
Regularization 0.1, non-linear iterations 128. The determined transformation from 
individual DTI space to MNI template space was then applied to all five DTI-based images: 
FA, MD, wbTDI, ewbTDI and ufTDI. 
 
2.7. Voxel-wise Statistical Analysis 
Spatially normalized FA, MD, wbTDI, ewbTDI and ufTDI of an individual brain were 
used for further voxel-wise statistical analysis. Every patient with MRI-negative focal 
epilepsy is different and therefore each patient has to be analyzed individually using an 
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approach suggested by Henson (Henson., 2006). First, the differences between one 
individual patient and each of the 42 healthy participants were calculated for each DTI-
based measure. The resulting 42 difference images were analyzed with one-sample T-test 
using SPM5 software for each patient, identifying voxels with significant deviations from 
the healthy population. We specifically tested for reduced FA, increased MD and reduced 
track density, correcting for multiple comparisons with the family-wise error method and 
thresholding at p<0.001.  
 
2.8. Regional Quantification 
To compare the sensitivity and specificity of the five different DTI-based measures, 
we divided each brain into 8 regions (left and right: frontal, parietal, temporal and occipital 
lobes) in MNI-space using MNI structural Atlas obtained from FSL software. Using fslstats, 
implemented in FSL, two parameters were determined from the statistical analysis of each 
DTI-based measure for each region: the highest T-score per region and the number of 
voxels in each region with a T-score larger than 8. 
To further evaluate the specificity of the DTI-based measures we assessed, for each 
cFE patient, how many lobes showed alterations larger than 20cm3 (Table I).      
Differences between cFE and CTR were assessed with two-sample t-test.  
 
3. Results 
3.1. Visualization of voxel-wise statistical analysis 
 In cFE, the visual inspection showed more widespread, bilateral and non-specific 
alterations in FA, MD and wbTDI. The alterations in ewbTDI were less extensive than in FA 
or MD, but still were more widespread than in ufTDI, where alterations were most 
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circumscribed and localized to one region (Fig. 1). In comparison to cFE, the alterations 
seen in 10 CTR were significantly smaller for all five DTI-based measures (Fig. 1). 
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Figure 1. Visualization of voxel-wise statistical analysis.  
Examples of five cFE patients and five CTR participants are used to show the differences in distribution of T-
scores and volume alterations in five DTI-based measures: FA, MD, wbTDI, ewbTDI and ufTDI, with low (blue) 
to high T-score (red). The results of SPM quantification were rendered together with a MNI template at a 
threshold T-score>5. The transparency of the template was increased to allow for the appreciation of the 
extent of alterations. For cFE patients, the clinical localization of the EZ is marked with an asterisk. 
 
3.2. Number of lobes with alterations 
Using a threshold of 20cm³ per lobe, FA quantification showed the most unspecific 
alterations. Only 10% of the patients had reductions in intensity in only one lobe of the 
brain, 20% of patients showed alterations in up to three lobes and 60% showed alteration 
in more than three lobes including 40% with FA reductions in all eight lobes (Table I). MD 
alterations were restricted to one lobe in only 10% of patients and 80% of patients showed 
alterations spreading to more than three lobes. The extent of the alterations was more 
restricted with TDI-based quantifications. A restriction of alterations to only one lobe was 
seen in 20% and 30% for wbTDI and ewbTDI, respectively. ufTDI alterations were most 
localized, in 60% of patients the alterations were restricted to only one lobe and the 
remaining 40% of the patients showed changes in up to three lobes (Table I). 
No. of lobes FA MD wbTDI ewbTDI ufTDI 
8 4 3 2 0 0 
7 0 2 0 0 0 
6 0 1 0 1 0 
5 2 2 1 2 0 
4 0 0 2 1 0 
3 1 0 0 2 2 
2 1 0 1 0 2 
1 1 1 2 3 6 
 
Table I. Number of lobes showing alterations in different DTI-based measures for all cFE patients.  
At a threshold of alteration volume of 20cm3, the frequency of alterations in eight lobes was counted for all 
DTI-based measures in 10 patients. The number of patients is color-coded with a gradient, where red 
represents the highest number of patients. Only in a few patients the alteration volume did not reach 20cm3 in 
any lobes for FA (n=1), MD (n=1), wbTDI (n=2) and ewbTDI (n=1).  
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3.3. Correlation with clinical data  
Statistical analysis of FA, MD, wbTDI, ewbTDI and ufTDI for 10 individual cFE 
patients and its regional quantification was compared to the clinical location of the EZ. The 
quantification of FA, wbTDI and ewbTDI showed the peak T-score of alterations in the lobe 
of the EZ in 20% of patients and MD identified the correct region in only 10%. In ufTDI 
quantification, 80% of patients showed the peak T-score in the correct region.  
Assessing the number of voxels above the threshold of T-score of 8 led to similar 
results as the peak T-score. Only 20% of FA, MD and ewbTDI and only 10% in wbTDI 
showed the correct lobe. ufTDI performed better than any other measure, with the highest 
number of voxels in the correct lobe in 60%.   
 
3.4. Differences between cFE and CTR quantification 
To determine the range of alterations in our DTI-based measures in healthy controls, 
the data of 10 CTR participants were analyzed, using the same quantitative procedure as for 
the 10 cFE patients.  
For all DTI-based measures, the peak T-scores of observed alterations were 
significantly higher in cFE than in CTR (FA p0.0001, MD p0.0015, wbTDI p0.007, 
ewbTDI p0.002, ufTDI p0.001; Fig. 2A).  
The volumes of alterations with a T-score >8 of all measures in cFE were also 
significantly larger in cFE than in CTR (Fig. 2B), which can also be appreciated visually (Fig. 
1). Within the CTR group, the median volume of significant alterations falls below 20cm³ for 
all five measures, whereas for cFE the median is above 30cm³. In the cFE group, FA 
quantification showed a wide distribution (Fig. 2B) with a median alteration volume of 
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91cm³. On the other hand, the volume of FA decrease for CTR was significantly lower with a 
median volume of 18cm³ (p6.6×10-5).  
The quantification of MD showed an increase in intensity. In the cFE group, the 
volume of this alteration had a median of 72cm³ compared to 10cm³ in the CTR group 
(p0.01). MD alterations showed a larger variability in CTR than FA accounting for the 
relatively high differences in p value 0.01.  
The quantification of track density images showed much smaller alteration volumes. 
For wbTDI the median volume of significant reductions is 34cm³ for cFE and 16cm³ in CTR 
(p0.006), similar to that of ewbTDI with a median of 35cm³ in cFE and 14cm³ in CTR 
(p0.0008) and ufTDI with a median of 36cm³ and 13cm³ for cFE and CTR (p0.0008), 
respectively.  
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Figure 2. Distribution of alterations for cFE and CTR groups for five DTI-based measures.  
For each DTI-based measure, the average peak T-score (A) and average number of voxels (B) and their 
corresponding interquartile range were calculated for all participants in each group. Color-coding depicts the 
DTI-based measure: FA (green), MD (blue), wbTDI (yellow), ewbTDI (orange) and ufTDI (red).  
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4. Discussion 
The localization of the epileptogenic zone (EZ) in patients with pharmacoresistant 
cryptogenic focal epilepsy considered for resective epilepsy surgery is challenging with 
current diagnostic methods.  
To increase the yield of MRI, different processing strategies have been proposed 
(other methods discussed in a review by (Kini et al., 2016)). Voxel-based morphometry 
(VBM) (Ashburner and Friston, 2000) using either T1 or T2 FLAIR has also been applied in 
MRI-negative epilepsy. However, similarly to FA and MD quantification, the yield was low. 
One study using VBM of FLAIR-images identified focal changes in 14.3% of 70 patients of 
which only half correlated with clinical data (Focke et al., 2009). Another study using 
morphometric analysis programme detected 1% more histologically proven FCD Type IIb 
than in conventional visual analysis (CVA), where CVA detected FCD in 91% of 74 cases 
(Wagner et al., 2011). This method was more successful at detecting FCD Type IIa 
pathology, where morphometric analysis detected 82% of histologically proven lesions 
compared to 65% using CVA (n=17).   
Recently, DTI has also been used as an additional diagnostic tool in a variety of 
diseases. Here we compared the diagnostic accuracy of different DTI-based measures to 
identify cryptogenic lesions in patients with focal epilepsy and showed that conventionally 
used DTI measures, like FA and MD, are not optimal in localizing the EZ.  
This is consistent with the few studies that used DTI for localization in MRI-negative 
patients, where the analyses of FA and MD maps have been disappointing. A study using 
voxel-wise statistical quantification identified an increase in MD in 8 of 30 MRI-negative 
patients of which only half corresponded to the ictal EEG recordings and two patients that 
showed alterations in FA, but only one was confirmed with ictal EEG (Rugg-Gunn et al., 
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2001). Another study, showed that increased MD identified the EZ, determined by the 
intracranial EEG, in 8 out of 20 patients (40%) (Thivard et al., 2011). Similarly to these 
studies, our quantification of FA and MD maps showed widespread alterations throughout 
the brain in most patients, insufficient to specifically identify the EZ. Specific changes 
restricted to the EZ were seen in only 20% of the patients. Our analysis with one sample t-
test of difference images increases sensitivity for single subject studies, which could explain 
the higher detection rate than what was reported in the aforementioned study (Rugg-Gunn 
et al., 2001), but this procedure does not improve specificity. The high specificity of our 
ufTDI quantification shows that ufTDI reflects different tissue properties than FA and MD, 
selectively detecting changes in the EZ of focal epilepsy. Perhaps FA and MD are more 
sensitive to secondary effects of epilepsy, seizures or medication, which cannot be 
distinguished from the primary alterations in the EZ.  
There is evidence of cytoarchitectural alterations at the grey-white matter border in 
the resected epileptogenic tissue from cFE patients (Blümcke et al., 2011), which might 
influence the tractography, by tracking fewer fibers in the vicinity of these epileptogenic 
changes. From our 5 DTI-based measures, ufTDI is most specific for the grey-white matter 
border and this could explain why ufTDI correlated best with clinical data, in 80% of our 
patients, which to our knowledge has not been achieved before in MRI-negative epilepsy.  
It is a common conception that every healthy brain is different. Therefore, it comes 
to no surprise that regional alterations of all DTI-based measures were also observed in the 
10 CTR participants we investigated, reflecting individual anatomic variability. However, 
these alterations had a much lower T-score and smaller volume than the alterations we saw 
in epilepsy patients for all five DTI-based measures. So in spite of their poor localizing 
value, even FA and MD could still separate healthy subjects from patients.  
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4.1. Limitations 
In this study, a rather small sample of 10 cFE patients were analyzed and 
confirmation of our results in a larger cohort is warranted. Another potential limitation is 
that the locations of DTI alterations are compared to the available clinical data. So far, only 
two patients underwent resective surgery, definitely confirming the EZ. However, for all 
patients there was conclusive clinical evidence for the location of the EZ, with no 
contradictory information from any diagnostic modality. Also, we have used a standard 
streamline tracking algorithm and perhaps more sophisticated algorithms, like HARDI 
(Tuch et al., 2002) or Q-Ball (Berman et al., 2008), would lead to different results. We are 
also aware of another DTI-based measure, called Neurite Orientation Dispersion and 
Density Imaging (NODDI) (Zhang et al., 2012). However, this requires a two shell DTI 
acquisition scheme, not readily available in a clinical setting and has not been applied to 
cryptogenic epilepsy.  
 
4.2. Conclusion  
Quantification of U-fiber track density images provides a novel diagnostic method of 
mapping the EZ in MRI-negative focal epilepsy, with much higher sensitivity and specificity 
than the currently used DTI measures FA and MD. We assume this reflects specific 
microstructural alterations at the grey-white matter border, where U-fibers are located.   
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Abstract 
Epilepsy surgery is the most efficient treatment for selected patients with medically 
refractory focal epilepsy. However, epilepsy surgery is challenging in non-lesional patients 
when conventional magnetic resonance imaging (MRI) fails to identify the underlying 
epileptogenic lesion. Here, we present a novel analysis method for single-subject Diffusion 
Tensor Imaging (DTI), based on reconstruction, quantification and statistical analysis of 
regional U-fibers, the most peripheral, short association fibers of the brain, located at the 
grey-white-matter junction. This new approach identifies previously undetected structural 
changes in 95% of 22 epilepsy patients with normal conventional MRI compared to normal 
controls. Seventy-five percent of these changes are localized in brain regions consistent 
with the epileptogenic zone. This novel diagnostic approach is a valuable tool in patients 
considered for resective epilepsy surgery, when conventional MRI fails to identify a surgical 
target. 
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Introduction 
Diffusion tensor imaging (DTI) is a recent MRI method, which allows in vivo studies 
of brain white matter and significantly contributed to important advances in clinical and 
theoretical neuroscience in the past years (Craddock et al. 2013). Traditionally, analyses of 
DTI data focused on fractional anisotropy (FA) images, which indicate the degree of 
directional bundling of white matter fibers. Anatomically, analyses have focused on the 
major white matter tracts which appear bright in FA images and which can be assessed 
reliably, even with low- or medium-quality DTI acquisitions. More recently, high-quality 
DTI acquisitions and processing methods provide rich datasets, with more detailed 
information on structural brain anatomy, from core white matter tracts to the most 
peripheral U-fibers of the brain. These peripheral regions appear dark in FA images (“dark 
side”) and deserve more attention and further investigation (Fig. 1).  
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Figure 1. U-fiber and long fiber projections tractography seen in a healthy brain.  
 
Epilepsy is a common serious neurological diseases and epilepsy surgery. i.e. the 
surgical resection of the epileptogenic zone is an effective and safe treatment for selected 
patients with pharmacoresistant focal epilepsies (Kuzniecky & Devinsky 2007; Wiebe 
2011). Presurgical evaluation aims to localize and delineate the epileptogenic zone using 
multiple diagnostic methods and depends strongly on neuroimaging (Duncan 2010). 
Patients with no visible structural lesion on conventional brain MRI scans typically have 
lower chances to become seizure free after surgery than patients with a lesion in MRI, 
providing a clear surgical target (Téllez-Zenteno et al. 2010; Henry 2014). However, more 
recent studies in non-lesional focal epilepsy showed better surgical outcome, as good as in 
lesional epilepsies when there is sufficient localizing information from complementary 
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functional imaging data, consistent with the clinical and electrophysiological data (Lazow et 
al. 2012). 
Improvement of imaging methods has led to higher detection rates of epileptogenic 
abnormalities, especially focal cortical dysplasia (FCD) (Mellerio et al. 2013). Despite these 
advances in neuroimaging, still up to 50% of referrals for epilepsy surgery in tertiary 
referral centers are patients with non-lesional or cryptogenic focal epilepsies (Nguyen et al. 
2013) which require more extensive pre-surgical evaluation, including invasive EEG studies 
with intracranial electrodes (Wiebe & Jette 2012; So & Lee 2014).  
Several neuroimaging approaches have been developed to improve localization of 
the epileptogenic zone in patients with non-lesional focal epilepsies (Madan & Grant 2009). 
These include analysis of conventional T1-weighted MRI data using morphometry, which 
has helped to identify hidden structural changes in some patients (Bernasconi et al. 2011; 
Huppertz et al. 2005). Advanced MRI acquisition schemes are also being developed (Feindel 
2013) and high field strength MRI at 7 Tesla is evaluated (De Ciantis et al. 2016). Functional 
imaging, such as single photon emission tomography (SPECT) (Sulc et al. 2014) and 
glucose-metabolism-based positron emission tomography (FDG-PET) (Rheims et al. 2013) 
can also provide complementary information to localize functional abnormalities. 
Magnetencephalography (MEG) has contributed additional localizing information in a few 
selected patients (Jung et al. 2013). All of these methods have some limitations. T1-based 
morphometry has low yield, providing additional information in only 10-30% of patients 
(Wagner et al. 2011; Srivastava et al. 2005). MEG, FDG-PET and ictal SPECT which should be 
performed during continuous EEG-video-monitoring are not readily available outside 
tertiary referral centers. Both SPECT and FDG-PET are expensive and involve significant 
radiation exposure.  
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Focal epilepsy is mainly a grey matter disease, caused by cortical neuronal 
hyperexcitability, while DTI is usually used to analyze brain white matter. FCD is one of the 
most frequent etiologies in focal epilepsy in patients with normal conventional MRI, often 
diagnosed histopathologically in specimens from resective surgery (Wang et al. 2013). FCD 
is a malformation of cortical development associated with impaired neuronal migration and 
altered architecture of the cortex and underlying white matter (Blümcke et al. 2011). 
Hallmarks of FCD are cortical thickening, blurring of the grey-white-matter border and 
ectopic neurons in the subcortical white matter. Contemporary, high-quality DTI data 
acquisition and processing allow to reliably reconstruct a comprehensive network of white 
matter connections, including small peripheral U-fibers, spanning from one gyrus to the 
neighboring gyri (Fig. 2), directly underneath the cortex, where FCD causes architectural 
alterations. Quantification of regional U-fiber density is therefore a specific approach to 
assess the brains microstructural properties in the proximity of the grey-white-matter-
border. 
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Figure 2. Schematic diagram showing the affected U-fibers in focal cortical dysplasia. Asterisk 
represents area affected by the pathology, which includes the blurring of the grey and white matter junction 
and the regional U-fibers.  
 
Additionally, U-fibers are important for regional feedback mechanisms, controlling 
activity levels within a brain area. Cortical inhibition, facilitated by interneurons, has been 
shown to be impaired in focal epilepsy (Badawy et al. 2009; Werhahn et al 2000.). Axons of 
inhibitory interneurons contribute a large proportion of connections in regional U-Fibers, 
but this has not been studied systematically. In a patient with focal epilepsy following 
hypoxic brain damage and normal conventional MRI, we could show regional U-fiber 
reduction in the epileptogenic zone, leading to impaired cortical inhibition and 
epileptogenicity (Feddersen, 2015). 
Here, we propose a novel analysis approach to DTI data, which can be easily 
acquired on a clinical routine MRI scanner. We show that reconstruction and statistical 
quantification of regional U-fiber density from DTI data can serve as a novel neuroimaging 
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biomarker, identifying regional structural changes at the grey-white-matter-border, which 
could not be detected by conventional MRI techniques in patients with focal epilepsy. 
 
Results 
Thirty consecutive patients with refractory focal epilepsy referred for pre-surgical 
evaluation were investigated. In all of them epilepsy oriented (conventional) state of the art 
3-Tesla MRI of the brain failed to reveal any structural lesion. Additional DTI images were 
acquired for all patients. All patients had prolonged Video-EEG monitoring and we included 
only those 22 with consistent clinical evidence for the localization of the epileptogenic zone.  
Eleven of the 22 included patients had electroclinical evidence of a single localized 
epileptogenic zone (frontal, n=6; temporal, n=3; central, n=2). Six patients had evidence for 
two epileptogenic zones in one hemisphere and five patients had clinical evidence for 
bilateral seizure onset.  
Fourteen patients were re-examined with invasive EEG after implantation of 
subdural electrodes (n=2) or stereotactic depth electrodes (n=12). Seven patients went on 
to have epilepsy surgery, and six are since seizure free (follow-up 6-18 months). In three 
patients, intracranial EEG showed bilateral epileptogenic zones, prohibiting resective 
epilepsy surgery. Four patients are currently awaiting surgery. 
In total, 48 clusters of voxels with significant reductions in U-fiber track density 
images (ufTDI) were found in 21 of 22 patients (95%): One single cluster was identified in 
three patients (14%), two clusters in ten (45%), three clusters in seven (32%) and four 
clusters in two patients (9%) (Fig. 3). Of these 48 clusters, 36 (75%) were consistent with 
clinically suspected epileptogenic regions, twelve (25%) did not match the clinical data. 
Three additional regions were clinically suspected in two patients but did not show 
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significant ufTDI reductions (6%). Of the twelve clusters not matching the clinical data, 
eight were ipsilateral to the epileptogenic zone and four were in the contralateral 
hemisphere.  
In the 14 patients with invasive EEG, 26 clusters were detected, 22 of which were 
covered by the intracranial electrodes. Intracranial EEG recording showed seizure onset in 
17 of these 22 clusters (77%).  
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Figure 3. Fiber tracking and results from quantitative analysis of ufTDI data for the first 16 
consecutive patients. These examples reflect the diversity in the cluster shape, size and locations in different 
patients. Red color shows the hotspot or the peak of the cluster. 
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Of the five patients with clinical evidence for bilateral epileptogenic zones, 4 showed 
extensive, bilateral changes in the quantitative ufTDI analysis. Bilateral seizure onset was 
confirmed by intracranial EEG recordings in three of them, precluding these patients from 
resective epilepsy surgery. One of these patients has subsequently undergone implantation 
of deep brain stimulation electrodes in the anterior thalamus, improving seizure control, 
and one had a vagal nerve stimulator implanted. 
Histopathological analysis of resected surgical specimen was performed in the seven 
operated patients, and showed mild architectural disturbances with blurred grey-white-
matter border and ectopic neurons (n=5), ganglioglioma (n=1) and normal brain tissue 
(n=1). 
 
We also investigated one additional patient with severe hypoxic brain damage, a 
pathology known to predominantly affect U-fibers. This patient had normal conventional 
MRI but ufTDI quantification showed extensive bilateral reductions of U-fiber density, to a 
degree and extent not seen in our epilepsy patients (Fig. 4). This serves as proof of concept 
and demonstrates the sensitivity of our method to detect damage to U-fibers. 
Chapter 3. On The Clinical Side   51 
           
 
 
Figure 4. ufTDI quantification in a patient with hypoxic brain damage. Images from the left to right: T2, 
conventional diffusion weighted images (DWI) and ufTDI quantification results. ufTDI showed extensive 
bilateral reductions, whereas neither T2 nor DWI showed any abnormalities.  
 
Discussion 
We present a novel analysis method for DTI data, based on tracking and 
quantification of regional U-fibers. U-Fiber track density images (ufTDI) were statistically 
compared with a sample of healthy controls. This novel approach identifies focal structural 
changes in patients with so-called cryptogenic focal epilepsy, where state-of-the-art 3 Tesla 
conventional MRI had failed to show the epileptogenic lesions. This method provides a new 
neuroimaging biomarker for microstructural alterations at the grey-white-matter-border, 
not visible in conventional epilepsy oriented MRI. DTI data was acquired on a 9-year-old 
clinical routine 3T Scanner, not requiring any specific hardware or software. Similar data 
can be acquired on almost all currently available MRI scanners. 
Almost all previous studies using DTI in epilepsy have been performed in patients 
with visible brain lesions, such as hippocampal sclerosis, and investigated DTI alterations 
beyond and remote from the lesion (Ahmadi et al. 2009) or their correlation with cognitive 
parameters (McDonald et al. 2014).  
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DTI has rarely been used as additional localizing method in non-lesional focal 
epilepsy. One of the few studies with a larger cohort used statistical analysis of mean 
diffusivity (MD) images in 20 epilepsy patients and reported regional MD increases with a 
sensitivity of 40% and specificity of 60% (Thivard et al. 2011). One recent DTI study also 
included patients with non-lesional temporal lobe epilepsy and failed to identify 
abnormalities in the major white matter tracts (Campos et al. 2015). However, this study 
only evaluated major, “bright” white matter tracts, which are less affected by focal cortical 
dysplasias. In contrast, our current study addressed U-fibers, in the “dark” and so far 
unexplored periphery of DTI images, specifically investigating the grey-white matter 
border, affected by FCD. Previous voxel based morphometry studies in epilepsy have 
repeatedly shown focal alterations of the grey-white matter border (Wagner et al. 2011), 
but with a much lower yield than with our approach. We recently compared ufTDI 
quantification against the conventional DTI measures FA and MD showed a much higher 
sensitivity and specificity of ufTDI for the detection of the epileptogenic zone in non-
lesional focal epilepsy (Goc, 2016, submitted). 
 
True positive findings 
With our approach, we were able to show clusters of reduced U-fiber track density, 
representing focal microstructural brain changes in 95% of the patients, and 75% of these 
clusters were consistent with clinical evidence on the epileptogenic zone. This sensitivity 
and specificity is higher than for other complementary neuroimaging methods in non-
lesional focal epilepsy (Thivard et al. 2011). The correct identification of the epileptogenic 
zone in previously non-lesional patients has several clinical consequences:  
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1) Some patients, where complementary functional investigations also remained 
inconclusive, would have been excluded from epilepsy surgery. Here, ufTDI facilitates that 
these patients benefit from surgery, by providing a target region for further investigation.  
2) If patients are candidates for epilepsy surgery but require intracranial EEG recordings, 
ufTDI can help in guiding the implantation of invasive electrodes, increasing the yield of the 
procedure and reducing the number of required electrodes, and thereby minimizing the 
risk of complications.  
3) Further, ufTDI showed extensive bilateral U-fiber reductions in all patients, where 
invasive recordings confirmed bilateral epileptogenic zones (Fig. 5). In these patients, not 
suitable for resective surgery, our new approach may help in the future to identify these 
patients earlier and to avoid the risks of invasive EEG recordings. 
 
Figure 5. Co-registration of intracranial EEG electrodes and clusters of significant ufTDI reductions. 
These images show co-localization of seizure onset (red electrodes) with ufTDI alterations. 
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False positive findings 
In about half of our patients, ufTDI showed more widespread changes, including 
additional clusters of ufTDI reductions outside the clinically determined epileptogenic zone. 
These additional areas were located ipsilateral to the epileptogenic zone in eight patients, 
but also included clusters in the contralateral hemisphere in four patients. Only one of those 
four contralateral clusters was the main (primary) cluster, the other three were smaller 
(secondary or tertiary clusters) in addition to the primary, correctly localizing cluster. 
There are different possible explanations for these additional clusters:  
1) False positive clusters may reflect secondary effects of chronic focal epilepsy, where 
areas remote from, but well connected to the epileptogenic onset zone, can show secondary 
changes. This would be typical for homologue areas in the contralateral hemisphere where 
lacking physiological input from the diseased side leads to inactivity or even regional 
atrophy on the contralateral side. Such remote effect may also be seen in areas belonging to 
the same functional system, similar to ipsilateral frontal hypometabolism observed in 
patients with mesial temporal epilepsy (Arnold et al. 1995; Wong et al. 2010). Follow-up 
scans of patients rendered seizure-free by surgery, may allow us to determine if some of 
these remote effects are reversible after seizure cessation.   
2) These false positive clusters may not be false positive after all. Not all patients who 
undergo resective epilepsy surgery become seizure free, and some develop recurrent 
seizures after a variable time of seizure freedom following surgery (Rosenow & Lüders 
2001). There are several reasons for this, such as incomplete resection, but also including 
dual pathology, where a second epileptogenic zone exists, but had not been detected at the 
time of the pre-surgical evaluation, probably because it was not yet epileptically active at 
that time. The fact that patients with non-lesional focal epilepsy tend to have a less 
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favorable outcome may indicate a higher proportion of such remote pathologies, extending 
beyond the assumed epileptogenic zone (Bernhardt et al. 2013). Clinically uncorrelated 
clusters of ufTDI reductions may represent such brain areas with structural alterations, 
currently not epileptogenic, but with the potential to become secondary seizure generators 
later on (Rosenow & Lüders 2001).  
3) Finally, these additional clusters could be unrelated to epilepsy and simply reflect more 
pronounced individual anatomical variations. In our current control population, we have 
not observed clusters larger than 5 cm³ at the threshold we use for analyses in epilepsy 
patients, but this does not preclude larger anatomical variations without pathological value. 
 
False negative findings 
No corresponding changes were seen in ufTDI for three brain regions with strong 
clinical evidence of the epileptogenic zone. This may be due to different reasons, which 
ultimately result in a reduced number of reconstructed U-fibers and hence may reduce the 
sensitivity or statistical power of our method. 1) Some brain areas have a lower amount of 
regional U-fibers than others, or a higher inter-individual variability reducing the statistical 
power. 2) Our selection criteria to identify U-fibers may not be ideal for all brain areas, for 
example, our length constrain of 20 - 60 mm may be too short to include longer U-fibers 
around a deeper sulcus, artificially reducing fiber density. 3) Technical artifacts, specific to 
some brain areas, may interfere with DTI data quality, such as susceptibility artifacts from 
the skull base, which interfere with the reconstruction of basal temporal fiber tracts.  
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Patient population, gold standard and confirmation 
All patients in our study underwent pre-surgical video-EEG monitoring, more than 
half of them with intracranial EEG recordings, the gold standard for identification and 
delineation of the epileptogenic zone in non-lesional focal epilepsy. Our ufTDI 
quantification could identify clusters of focal reductions in all of these patients, and 
intracranial EEG confirmed seizure onset in 77% of the identified clusters.  
In those without intracranial EEG, the epileptogenic zone was defined by conclusive 
interpretation of all available diagnostic information, including non-invasive video-EEG 
monitoring, ictal SPECT, PET and clinical data. The percentage of correlation was not 
significantly different in these patients, with 73% of ufTDI clusters correlating with the 
clinical data. This indicates, that our observed correlations do not depend on the way, the 
epileptogenic zone was identified.  
 
Histopathology 
The most frequent histopathological finding in resected surgical specimen from our 
patients is a mild architectural disturbance with blurred grey-white-matter border and 
ectopic neurons in the subcortical white matter, not enough to fulfil the current 
histopathological criteria for FCD (Blümcke et al. 2014). We assume, that these subtle 
histological changes disrupt the DTI tracking algorithm through a less consistent fiber 
alignment, disturbed by ectopic neurons in the white matter. It is important to clarify that, 
rather than showing white matter fibers directly, DTI and tractography actually show 
reconstructed pathways of water diffusion, resembling the white matter fibers described in 
anatomical studies. Hence, the reduction of U-fiber density we observe in our patients may 
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reflect an actual reduction of the number of anatomical U-fibers but could also reflect focal 
changes interfering with the tracking algorithm.  
Further correlation with histopathology results from more patients, the comparison 
of different fiber types and different tracking algorithms, and the inclusion of additional 
parametric DTI and other MR images will allow us to look into the biological nature of the 
underlying alterations in more detail. Should different alteration patterns emerge, this may 
allow us to predict histological changes from specific profiles of alterations in DTI data. That 
we currently do not know the exact mechanism underlying our observed reductions in 
ufTDI does not decrease its important clinical value for patients with medically refractory 
non-lesional focal epilepsy.  
 
Conclusion 
Our novel user-independent DTI analysis method is able to identify subtle focal 
structural changes at the grey-white-matter border not seen in conventional MRI. This 
approach should be considered in patients with “non-lesional” focal epilepsy to localize the 
epileptogenic zone. This additional localizing information has an impact on the 
management of these patients, by helping to identify candidates for intracranial evaluation 
and guidance of the electrode implantation. This same method may also be suitable to 
identify patients with extensive bilateral alterations, who are not candidates for resective 
surgery, sparing them unnecessary invasive investigations. 
 
Outlook 
Further analyses of different fiber populations and long-term follow-up of patients 
will further our understanding of the mechanisms of epileptogenesis, seizure propagation 
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and secondary epileptogenesis, as well as compensation mechanisms and long-term effects 
of chronic focal epilepsy.  
Similar changes, with subtle alteration of peripheral fibers may also be found to 
underlie other neurological disorders, such as neurodegenerative disease, where state-of-
the-art structural MRI fails to show specific pathological changes in early stages of the 
disease and where the dark side of DTI data also has not been explored so far. 
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(Online) Methods 
Study population 
We investigated 30 patients with refractory focal epilepsy referred for pre-surgical 
evaluation at the University of Munich Hospital between 2013 and 2015. All patients had 
more than one conventional MRI, including a dedicated epilepsy protocol on a 3T scanner 
evaluated by at least 2 experienced neuroradiologists and epileptologists, all MRI scans 
were reported normal. Comprehensive pre-surgical evaluation allowed hypothesizing a 
single seizure onset zone in 22 of the 30 patients, based on the conclusive interpretation of 
scalp EEG, seizure semiology, ictal SPECT imaging (n=11) and FDG-PET (n=13). In the 
remaining 6 patients, the pre-surgical evaluation was inconclusive, i.e. the epileptogenic 
zone could not be lateralized or was only lateralized to one hemisphere but with no further 
lobar localization. All patients are candidates for further invasive evaluation, using 
intracranial depth or subdural electrodes.  
 
For comparison we have scanned 31 age- and gender matched healthy controls with no 
prior history of neurological disease and normal structural MRI scan. 
 
Figure 6 shows the workflow of the method starting with the pre-processing of the diffusion 
weighted images to ufTDI quantification in SPM.  
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Figure 6. Workflow of DTI data processing and analysis. 
 
MRI 
Clinical MRI was performed on a GE Signa HDx 3T scanner, using a dedicated epilepsy 
protocol, including 3D T1, coronal T1 inversion recovery, coronal T2, coronal and axial 2D 
FLAIR and a 3D sagittal FLAIR sequence.  
 
DTI imaging 
DTI data was acquired on the same scanner in a different session, using an acquisition 
scheme with 64 diffusion-weighted directions, a b-value of 1000m/s², 2.4 mm slice 
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thickness and a 96x96 matrix within a 220mm field of view, resulting in a 2.3 mm in-plane 
resolution. Using one excitation per volume, the acquisition time was 17:36 minutes. 
 
DTI processing 
Image volumes were resampled to isotropic 1mm voxel size and realigned to correct for 
movement and eddy current induced distortions with FSL software 
(http://fsl.fmrib.ox.ac.uk). Diffusion tensors were fitted and fractional anisotropy (FA) and 
mean diffusivity (MD) maps were created. The resulting FA maps were spatially normalized 
to a FA template in MNI (Montreal Neurological Institute) space using SPM5 software 
(http://www.fil.ion.ucl.ac.uk/spm) to determine a nonlinear transformation with a 12mm 
frequency cutoff, a regularization of 0.1 and 128 nonlinear iterations. Whole-brain 
deterministic streamline tractography was performed in native individual subject space 
with diffusion toolkit (http://trackvis.org), using an FA threshold of 0.1 and an angular 
threshold of 35° between voxels, resulting in an average of 1.04 million fiber tracts per 
subject (range 0.87 - 1.22million). From these fiber tracts, we selected U-fibers with the 
command-line tool track_vis, using a length constraint of 20 - 60 mm, curvature of 5 - 10 
and a U-factor, which estimates the shape of a fiber, of 0.6 – 1 (range -1 to 1). This resulted 
in an average of 84 thousand U-fibers per subject (range 65 – 107), which were used for 
subsequent analyses. 
 
Statistical analysis and quantification of DTI data 
For user-independent, automatic analysis of U-fibers, we subsequently created U-Fiber 
track density images (ufTDI), where each voxel is assigned the number of U-fibers passing 
through it. The ufTDI were then spatially normalized to MNI space, applying the 
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transformation previously determined from the FA normalization. Spatially normalized 
ufTDI were smoothed with an 8mm FHWM kernel.  
For the clinical purpose of localizing the previously undetermined epileptogenic area of a 
patient, each patient needs to be analyzed as a single individual. We have, therefore, chosen 
the approach suggested by Henson (R. Henson 2006) for single subject analysis, where 
difference images are created for every patient, subtracting the ufTDI of every single 
control from the ufTDI of the patient.  
The resulting 31 difference images were then analyzed using a one sample t-test in SPM, 
identifying areas of consistent decrease of U-fiber density.  
We chose the threshold of p<0.001, with family-wise error correction for multiple 
comparisons and a spatial extend threshold of at least 5000 contiguous voxels (equivalent 
to 5 cm³ volume) to eliminate small volume noise.  
Clusters of decreased U-fiber density were visualized in SPM glass brain view, sectional 
images overlay and 3D surface rendering. Clusters were also back-normalized from MNI-
space into the patient’s individual DTI data and superimposed with the U-fiber rendering to 
allow visual inspection of fiber tracts in the regions detected as statistically significant. 
 
For the purpose of this study, regional increases in ufTDI were not analyzed. However, 
future studies should address this in view of potential compensatory changes outside the 
epileptogenic zone. 
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Abstract 
A recent approach to localize the epileptogenic zone (EZ) in patients with 
cryptogenic focal epilepsy (cFE) based on the quantification of U-fiber track density images 
(ufTDI) showed better results than the quantification of FA or MD. However, the analysis 
involves a complex processing pipeline, where every processing step should be evaluated 
and optimized. Here, we looked at the effects of three different spatial normalization 
procedures, a U-fiber-specific masking and two different tracking algorithms on the final 
ufTDI results. 
22 patients with MRI-negative focal epilepsy were compared against 31 healthy 
controls. DTI data was acquired on a 3T GE Signa HDx Scanner with 64 diffusion-weighted 
directions and b-value of 1000 s/mm². DTI data was pre-processed, whole brain 
deterministic streamline tracking and HARDI tracking were performed and ufTDI were 
created, counting the number of U-fibers passing through any voxel. The ufTDI of each 
participant was spatially normalized to a template in MNI-space using three different 
approaches: SPM with default settings (SPMd) and optimized parameters (SPMo) and 
Advanced Normalization Tools (ANTs). A statistical comparison to the healthy control 
population was carried out, using a whole brain mask or the U-fiber-specific mask. The 
resulting clusters of significant ufTDI reductions, in every individual patient, were 
compared to the clinical localization of the EZ. 
 All three spatial normalization procedures showed comparable results, identifying 
primary clusters of reductions at similar locations with an average overlap of 71.5%. 
Results based on the SPMo spatial normalization showed the highest correlation with the 
clinical data and strongest statistical significance. Using a U-fiber-specific mask, instead of 
the MNI152_T1 whole brain mask reduced the volume of false-positive clusters by 31.6%. 
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Deterministic streamline tracking showed fewer tertiary clusters than when using HARDI 
tracking. 
Quantification of ufTDI is a robust method to localize the EZ in cFE. However, 
optimization of several processing steps along the analysis pipeline can help to increase 
sensitivity and specificity of the results, mostly by reducing the number of false positive 
findings.   
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Abbreviations: DTI = diffusion tensor imaging; MRI = magnetic resonance imaging; SPM = 
statistical parametric mapping; ANTs = advanced normalization tool; cFE = cryptogenic 
focal epilepsy; CTR = control; EZ = epileptogenic zone; ufTDI = U-fiber track density image 
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1. Introduction 
Epilepsy is one of the most common neurological disorders affecting up to 1% of the 
population, where 30% of patients have pharmacoresistant epilepsy. In some of these 
patients, resective epilepsy surgery can be an effective treatment option (Rosenow and 
Lüders, 2001). Up to 50% of the candidates for surgery have “non-lesional”, cryptogenic 
focal epilepsy (cFE), where conventional MRI does not show the underlying structural 
lesion. No single diagnostic method alone is available for the localization of the 
epileptogenic zone (EZ) (Kudr et al., 2013). The correct localization of the EZ and its 
complete resection are crucial for postoperative seizure freedom. The most frequent 
structural pathology in focal epilepsy is focal cortical dysplasia (FCD) characterized by 
histological abnormalities of the laminar layer of the cortex, blurring of the white and grey 
matter border, dysmorphic neurons and balloon cells (Besson et al., 2008; Blümcke et al., 
2011).  More severe forms of FCD can be detected by conventional MRI, but the changes can 
also be subtle and then may be easily overlooked on visual inspection of MRI or may not be 
visible in conventional MRI at all (Besson et al., 2008).  
The use of diffusion tensor imaging (DTI) for identifying hidden lesions in cFE 
patients is less common. Quantification of the track density images (TDI) of short 
association fibers, called U-fibers, obtained from DTI has been shown to localize the EZ 
more effectively than quantitative analysis of fractional anisotropy (FA), mean diffusivity 
(MD) or whole brain track density images (Goc et al., submitted). This approach provides a 
novel and efficient diagnostic tool in cFE, offering additional valuable information for the 
localization of the EZ (Vollmar et al., in prep). 
The ability to accurately compare DTI data across brains of many individuals relies 
on spatial normalization to transform individual brain scans onto a common template thus 
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allowing further comparison and voxel wise analyses. There are two types of approaches: 
volume-based and surface-based. The former, more common type, uses voxel intensities to 
steer the spatial normalization and uses full brain volume (Ghosh et al., 2010; Klein et al., 
2009), whereas the latter takes into account the cortical surface alone, i.e. the shape of sulci 
and gyri (Fischl et al., 1999). The choice of the type of spatial normalization is likely to affect 
the results of cross subject analyses. Here we are interested in the reductions in fiber 
density and therefore volume-based spatial normalization is more applicable for this 
purpose.  
Here we report the effects of the software and parameters for volume-based spatial 
normalization, a U-fiber-specific masking and different tracking algorithms on the 
quantification of U-fiber track density images (ufTDI).  
 
2. Methods and Participants 
2.1. Participants 
A group of 22 patients [mean age of 31 (SD: 12.4), 11 males] diagnosed with drug-
resistant cryptogenic focal epilepsy (cFE) was investigated. All patients had conventional 
structural MRI at 3T, not showing any structural epileptogenic lesions and underwent a 
series of neurological examinations including scalp EEG and video monitoring, FDG-PET, 
SPECT and in some cases invasive intracranial EEG.  
31 healthy participants with no previous neurological or psychiatric history were 
included in the control (CTR) group [mean age of 28 years (SD: 6.4), 24 males]. 
The University of Munich Ethics Committee approved the study and all participants 
have given a written and informed consent.  
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2.2. DTI acquisition and pre-processing 
All participants had additional DTI data acquisition on a 3T GE Signa HDx Scanner 
with an 8-channel head coil using 64 diffusion-weighted directions, a b-value of 1000 
s/mm², 60 axial slices with 2.4 mm slice thickness, a 96x96 in-plane matrix with a 220mm 
field of view, TR 16000 ms, TE 90.2 ms, flip angle 90° and parallel imaging with a SENSE 
factor of 2. 
DTI-images were resampled to isotropic 1mm voxel size and corrected for 
movement and distortions caused by eddy currents using FSL software 
(http://fsl.fmrib.ox.ac.uk).  Skull-stripped, realigned images were processed with FSL dtifit 
to create fractional anisotropy (FA) maps. 
 
2.3. Tracking and U-fiber selection 
Deterministic streamline tracking (DST) seeding from every voxel within the brain 
was performed with the Diffusion Toolkit (http://trackvis.org/) using a 2nd-order Runge 
Kutta propagation algorithm with an angular threshold of 35°. The termination criteria of 
the tracking were either exiting the brain or when the FA value in a voxel was <0.1. The 
streamlines were then visually analyzed in TrackVis (http://trackvis.org/) to check for 
erroneous tracking. The average whole brain track counts for cFE and CTR were 951699 
and 1025380, respectively. 
Additionally, in the first 10 cFE patients, the same DTI data was used for a high 
angular resolution diffusion imaging (HARDI) tracking performed with Diffusion Toolkit. 
The termination criteria, visual verification and U-fiber selection were the same as for DST 
tractography, except for an angular threshold of 45°. The average whole brain track counts 
for cFE and CTR using HARDI tracking were 1136809 and 1240378, respectively.  
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The population of U-fibers was selected from the whole brain tracking data using the 
following selection parameters: length 20-60mm, curvature 2-10 and U-factor, describing 
the shape of a fiber, between 0.6-1. These were then used to create U-fiber track density 
images (ufTDI) (Goc et al., submitted).  
 
2.4. Spatial Normalization 
We compared two commonly used volume-based programs for affine and nonlinear 
spatial normalizations: SPM (Ashburner et al., 1999) and Advanced Normalization Tools 
(ANTs) (Avants et al., 2011). The FA maps were spatially normalized to the FMRIB58_FA 
template in MNI space provided by FSL. The following three different spatial normalization 
procedures were compared: 
SPM default (SPMd) – using default parameters provided by SPM5. 
SPM optimized (SPMo) – with the following adjustments: source image smoothing 
(from 8 to 5mm), non-linear frequency cut-off (from 25 to 12mm), non-linear 
regularization (from 1 to 0.1) and non-linear iterations (from 16 to 128).  
ANTs optimized (ANTs) – using the SyN algorithm with a regularization of SyN 0.5, 
smoothing 5mm and a 4x2x1 subsampling scheme with 30x90x150 nonlinear 
iterations.  
The determined transformation from individual FA maps to the FA template was then 
applied to ufTDI before further statistical analyses. 
 
2.5. Voxel-wise Statistical Analysis 
Spatially normalized ufTDI of an individual brain was used for the voxel-wise 
statistical analysis based on the method described elsewhere (Goc et al., submitted). First, 
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the differences in ufTDI maps between each individual patient and the group of 31 controls 
were calculated (Henson, 2006). The resulting 31 difference images were analyzed with 
one-sample t-test using SPM to identify clusters of voxels with decreased track density 
compared to the CTR group. After family wise error (FWE) correction for multiple 
comparisons, the results were analyzed at the threshold of p<0.001 and a spatial extent 
threshold of >5000 voxels (5cm3).  
 
2.6. U-fiber-specific explicit mask 
Additionally, a U-fiber-specific mask was created to constrain statistical analysis to 
regions with a sufficient U-fiber density by averaging the spatially normalized ufTDIs of all 
participants. This average was then smoothed with 8mm FWHM, thresholded at 3 and 
binarised. Using FSL atlas tool, subcortical structures (brainstem, caudate, putamen, 
pallidum, thalamus and lateral ventricles) and cerebellum were subtracted from the mask. 
This U-fiber-specific mask was compared to the conventionally used MNI152_T1 whole 
brain mask before statistical analysis in a sample of 10 cFE patients using the SPMo 
normalization.  
 
2.7. Classification of clusters 
In most of the patients, the quantification of ufTDI showed multiple clusters of 
voxels with ufTDI reductions varying in spatial extent and degree of significance. 
Occasionally, there are clusters with a high T-score that are unlikely to be true findings, 
usually located in regions where no U-fibers are present, presumably due to e.g. DTI 
acquisition or spatial normalization artefacts. Therefore, to overcome these issues, we have 
ranked clusters based on their weight defined by: 
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Equation 1. Calculating the cluster weight. 
Cluster volume is based on the number of voxels thresholded at p <0.001 and cluster T-score is the maximum T-
score of any voxel within this cluster. 
cluster weight = (cluster volume) × (cluster peak T-score) 
 
The primary cluster is the one with the highest cluster weight per participant. 
Tertiary clusters have a cluster weight smaller than 10% of the primary cluster. Secondary 
clusters are all clusters in between.  
 
3. Results 
3.1. Spatial normalization procedures 
The quantification of ufTDI showed clusters of statistically significant decrease in 
track density in all patients for all three spatial normalization procedures. Overall ufTDI 
quantification identified 45, 49 and 51 clusters for SPMd, SPMo and ANTs, respectively. We 
restricted further analyses to the primary cluster of every patient. Compared to the clinical 
information about the localization of the EZ, the ufTDI quantification correctly identified the 
EZ in 79%, 85% and 74% of primary clusters using SPMd, SPMo and ANTs normalization, 
respectively.  
In general, the three spatial normalization procedures lead to very similar statistical 
results. However, there are differences, which can be appreciated visually and 
quantitatively. On average, the volume of primary clusters was bigger in SPMd by 3% 
compared to SPMo. The volume of the clusters was bigger in ANTs than SPMo by 6.5% and 
SPMd by 3.9%. 
The peak T-score obtained by the quantification of ufTDI was significantly higher in 
cFE than in CTR for all three spatial normalization procedures (Fig.1). The average peak T-
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scores for primary clusters in CTR and cFE groups were 12.0 and 15.1 for SPMd (p=4x10-3), 
12.2 and 16.3 for SPMo (p=8.66x10-7) and 12.2 and 16.0 for ANTs (p=1.46x10-5), 
respectively, showing that the difference between cFE and CTR was most significant using 
the SPMo spatial normalization procedure.   
 
 
 The quantification based on all three spatial normalization procedures showed the clusters 
in similar regions (Fig. 2) with 71.5% average overlap of the three clusters in each patient 
(Table 1).  
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Figure 1. Significance of ufTDI reductions in CTR and cFE patients based on three different spatial 
normalization procedures.  
For each spatial normalization procedure, the average peak T-score of ufTDI quantification and its 
corresponding interquartile range was calculated for each group.  
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3.2. U-fiber specific mask  
The effects of a U-fiber-specific mask on the cluster volume obtained in 
quantification and visual impression were evaluated in 10 cFE patients. Quantification of 
ufTDI using a U-fiber-specific explicit mask, resulted on average in 31.6% smaller volume of 
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Figure 2. Visualisation of the ufTDI quantification based on three different spatial normalization 
procedures in the same patient.  
ufTDI quantification showing a single cluster extending from the right postcentral gyrus in the parietal 
lobe to the temporal lobe. Clinically, the patient had somatosensory auras with tingling of the left hand 
consistent with the postcentral location of the cluster. SPMo shows the most significant reduction in the 
postcentral gyrus comparing to SPMd and ANTs. The 3D mesh is rendered at the smoothed grey-white-
matter border of the MNI152T1 template. The color-coded overlay shows one patient’s statistically 
significant reductions of the ufTDI compared to controls. 
 
Table 1. Average degree of overlap between quantifications based on different spatial 
normalization procedures.  
The percentage of the overlap of clusters from two different quantifications was calculated. The top row 
indicates what the overlap was for a particular quantification, e.g. the overlap between SPMd and SPMo 
was 69% of SPMo-based cluster and 73% of SPMd-based cluster.  
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clusters compared to using the MNI152_T1 whole brain mask. With the U-fiber-specific 
mask, several of the false-positive clusters were removed from anatomical regions where U-
fibers are not typically present (Fig. 3). For this reason, the remaining analyses were based 
on the quantification using the U-fiber-specific explicit mask.  
 
 
 
3.3. DST versus HARDI tracking 
The comparison of the effects of DST and HARDI tracking algorithms on the 
quantification of ufTDI was performed for 10 cFE patients using SPMo spatial normalization 
and the U-fiber-specific mask. On average, HARDI tracking resulted in 16% more whole-
brain fibers and 36% more U-fibers than DST.  
The ufTDI quantification based on HARDI tracking showed a slightly lower average 
T-score for primary clusters (16.26) than DST (16.98). The total number of clusters 
detected in these 10 patients was higher in HARDI (n=34) than in DST (n=23). Typically, the 
additional clusters were tertiary clusters or noise (Fig. 4).  
Figure 3. Effects of masking on ufTDI quantification.  
(A)  SPMo-based quantification using MNI152_T1 whole brain mask showed clusters in regions were U-
fibers are not typically found, e.g. cerebellum. Those clusters are masked out using (B) U-fiber-specific mask. 
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Generally, the primary clusters were detected at similar locations and had a 
comparable shape for all patients. In terms of correlation with the electroclinical data, the 
same primary clusters were correctly identified in all 10 cFE patients with both DST and 
HARDI tracking. However, of all known clusters, including secondary clusters, 76% 
matched the clinical localization of the EZ when using DST and 65% in HARDI.  
 
 
Figure 4. Visualisation of the ufTDI quantification based on different tracking algorithms in the same 
patient. 
ufTDI quantification results based on (A) DST and (B) HARDI tracking.  
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4. Discussion 
In cryptogenic focal epilepsy (cFE), localization of the epileptogenic zone (EZ) is 
challenged by the absence of a visible lesion in conventional MRI and relies on 
complementary diagnostic methods. DTI might be able to detect microscopic changes due 
to disruptions of the cortical laminations (Rugg-Gunn et al., 2001; Martin et al., 2015; Goc et 
al., submitted; Vollmar et al., in prep) in the area causing epilepsy. The use of DTI data 
allows for the analysis of structural differences in regions of the hypothesized EZ by 
quantifying U-fiber track density images (ufTDI). However, the processing pipeline of such 
analyses is complex, involving pre-processing, tracking, spatial normalization, masking, etc. 
and each step may affect the final results. Here, we focused on evaluating the effects of the 
spatial normalization and masking. We chose two commonly used volume-based software 
packages for this purpose: SPM and ANTs. 
 We expected for this step to be important, as it might directly relate to the accuracy 
and reliability of the results later on (Ghosh et al., 2010). However, we showed that the type 
of normalization and the optimization of parameters do not fundamentally influence the 
results of the quantification, i.e. the majority of primary clusters remain at the same 
location in all three spatial normalization procedures. The type of spatial normalization has 
an impact on the amount of secondary and tertiary clusters and the amount of general 
noise. It has been reported that ANTs performs better at registering the native brain to a 
reference image than SPM does (Ghosh et al., 2010). In our data, the apparent changes in 
ufTDI are robust enough that the different spatial normalization procedures do not 
significantly change the results of statistical quantification.  
It is difficult to assess which spatial normalization procedure is best to improve the 
quantification. We still do not know whether presence of more or fewer clusters is better or 
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worse. We do know that altogether, SPMd normalization lead to the lowest number of 
clusters, however, cluster location based on SPMo correlated best with the clinical data.  
Here, we only evaluated the primary clusters, but we do know that in some patients, the EZ 
might extend to more than just one region. SPMd showed higher correlation of the primary 
clusters with the clinical data than ANTs did by 5%, whereas SPMo identified 6% more 
clusters than SPMd did. All three are within a close range and the clusters largely 
overlapped. It is important to take into account the computation time and ANTs has shown 
to be more demanding and time-consuming than SPMo (Ghosh et al., 2010), while the 
results were similar.   
On the other hand, the U-fiber-specific explicit mask used in the quantification had a 
major effect on the results. All primary clusters remained at the same location, but the total 
size of all clusters significantly decreased by 31.6%, mostly by eliminating artefactual 
secondary and tertiary clusters.  
Every brain has its own individual characteristics, meaning that there will be 
clusters of reduced ufTDI present in every brain including healthy controls (Goc et al., 
submitted). To determine the threshold, separating CTR from cFE, we have also performed 
statistical ufTDI quantification in the CTR group and compared the results to those from 
cFE patients. The distribution of T-scores clearly separates CTR and cFE groups (see Fig. 1). 
Together with other indications (e.g. cluster weight, cluster shape, etc.), this separation 
might be used as a threshold to determine the validity of the cluster.  
We have compared ufTDI quantifications based on both DST and HARDI tracking 
algorithms, which have both correctly identified the same primary clusters. But –similarly 
to the spatial normalization procedures – changes in the tracking algorithms affected the 
amount of noise and false-positive clusters. In our series, HARDI-based quantification 
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showed more clusters that were not correlated with the electroclinical data. Compared to a 
simple DST tracking algorithm, HARDI is optimized to decipher multiple fiber orientations 
within a single voxel (Tuch et al., 2002) and is more capable to overcome crossings. This 
could account for a different distribution of reconstructed tracts and the additional clusters 
seen in HARDI-based quantification. However, the effects of different tracking algorithms 
on ufTDI quantification to localize the EZ should be investigated in more detail.  
 
4.1. Conclusion  
For a complex analysis pipeline, such as statistical quantification of ufTDI, every 
step, from the data acquisition to the statistical analysis, matters and every step should be 
optimized to obtain the best results possible for a given question. None of the differences 
we investigated have resulted in a failure to correctly identify the primary cluster of ufTDI 
reductions, also illustrating the robustness of this approach. However, the choice of the 
most appropriate alternative for every step throughout the processing pipeline has reduced 
the number of false-positive findings, reduced the amount of noise, strengthened the 
separation of patients from controls and improved the specificity of findings.  
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Abstract 
DTI is becoming increasingly used as a diagnostic tool in neurology. Recently, we proposed 
a new DTI-based diagnostic method that localized the epileptogenic zone in patients with 
cryptogenic focal epilepsy (cFE) by quantifying U-fiber track density images (ufTDI) in 
comparison to a healthy control population. We also showed that optimizing the steps in 
the complex pre-processing pipeline improves the specificity of the ufTDI quantification. 
Another unexplored aspect of this approach is the effect of the control population on the 
quantification. In neuroimaging studies, there are still open questions regarding the 
composition of the correct control group and it may be selected inadequately. The effects of 
gender-matched control groups are rarely investigated and to our knowledge, no single-
subject study has evaluated them.  
Here, we investigated different effects of the composition of the group of healthy 
controls (n=60) on ufTDI quantification in cFE patients (n=48). DTI data was acquired for 
all participants on a 3T GE Signa HDx Scanner with 64 diffusion-weighted directions and b-
value of 1000 s/mm². DTI data was pre-processed and whole brain streamline tracking was 
performed and U-fibres were selected to create ufTDI. Statistical comparisons of single 
individual patients to the varying healthy population (HP) groups were carried out to 
identify changes in the final results of the ufTDI quantification.  
The results showed that increasing size of the HP group increases the statistical 
significance of the ufTDI quantification and improves the separation of healthy controls 
from cFE patients. The separation was further strengthened by removing outliers from the 
biggest HP group. When using a gender-matched HP group, the overall volume of ufTDI 
reductions decreased by 17% for male and 21.5% for female patients. At the same time, the 
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primary clusters amongst all groups and patients remained at the same location and only 
the additional clusters, e.g. noise clusters, are affected.  
In summary, we showed that careful selection of controls affects the amount of noise 
and additional clusters without fundamentally changing the primary cluster.  
 
 
Abbreviations: DTI = diffusion tensor imaging; MRI = magnetic resonance imaging; ufTDI = 
U-fiber track density image; cFE = cryptogenic focal epilepsy; CTR = control; HP = healthy 
participants 
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1. Introduction 
Identifying micro-structural lesions using diffusion tensor imaging in patients with 
‘non-lesional’ cryptogenic focal epilepsy (cFE) is new. In drug-resistant patients, the correct 
localization of the epileptogenic zone (EZ) and its complete surgical resection are crucial to 
achieve seizure freedom (Rosenow and Lüders, 2001). Recently, a new approach of 
quantifying track density images (TDI) of short association fibers, called U-fibers, obtained 
from DTI has been introduced (Goc et al., submitted). It has shown to localize the EZ more 
effectively than a quantitative analysis of commonly-used fractional anisotropy (FA), mean 
diffusivity (MD) or whole brain track density images. A following study showed that 
optimizing steps of the pre-processing pipeline, like spatial normalization or the use of a U-
fiber-specific mask, improved the sensitivity and specificity of the method (Goc et al., in 
prep). These studies did not yet evaluate the role of the control group for statistical 
comparison and its effects on the final statistical results.  
The quantification of U-fiber track density images (ufTDI) is based on statistical 
comparison of one individual cFE patient against a group of healthy controls, which is able 
to identify clusters with significantly decreased track density in individual cFE patients. The 
primary cluster has been shown to correlate well with the clinically-determined EZ (Goc et 
al., in prep). Often there are additional, smaller clusters of reduced track density that are 
thought to represent false-positive findings. These could be due to a number of factors, e.g. 
individual anatomical variability, the sample size and composition of the control group. 
In neuroimaging studies, there are still open questions regarding the composition of 
the correct control group and it is occasionally poorly selected (Greene et al., 2016). This is 
particularly true for new methodological approaches, such as the ufTDI quantification, 
where the sample size necessary for statistical analyses or comparisons is unknown. 
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Underpowered studies are prone to low chance of discovering a true effect and even if that 
effect is found, most likely the relative magnitude of that effect would be exaggerated (the 
so-called “Winner’s curse”, Button et al., 2013). Too small size of a control group could 
prevent the discovery of the true effect and increasing the number of controls might 
improve the power of a study. However, this association is not linear and beyond a certain 
number of controls, there is little improvement in the power of the study (Grimes and 
Schulz, 2005). Finding the optimal number of controls for neuroimaging studies remains a 
challenging task, especially for a single-subject study against group comparison that we 
perform here.  
It has been shown that gender-specific differences are present in the human brain. A 
number of studies over the last decade studied sex dimorphism using neuroimaging 
methods, such as fMRI, voxel-based morphometry (VBM) and DTI (Sacher et al., 2013). 
Sexual dimorphism was investigated at great length, primarily looking into the overall brain 
size, where male brain volume is larger than female’s brain, or investigating the proportion 
of white to grey matter, where women showed to have a higher proportion of grey matter 
(Sacher et al., 2013). These differences can influence statistical analyses such as our ufTDI 
quantification and could result in both reduced sensitivity and false-positive findings and 
increased noise in case of gender mismatch. Additionally, recent structural studies have 
shown regional differences in brain volume, where men showed an increased volume of 
midbrain, left inferior temporal gyrus, right middle temporal gyrus and cerebellum (Chen et 
al., 2007). Women showed greater volume in cingulate cortices (Chen et al., 2007) and 
auditory and language-related areas (Brun et al., 2009).  
In most neuroimaging studies, mixed control groups are used and the gender of the 
controls is not necessarily considered, e.g. for mixed patient group, a mixed control group is 
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assembled. Occasionally, when a gender-related disease is investigated, e.g. prostate cancer, 
then naturally it would involve a male control group. However, the effects of using a gender-
specific control group are rarely investigated and to our knowledge, no single-subject study 
has evaluated the effects of single-patients against mixed control group compared to a 
gender-specific control group.  
Basically, the control population should be similar to the patients in all regards, 
except for the disorder in question (Grimes and Schulz, 2005; Schulz and Grimes, 2002). 
Therefore, here we evaluated the effects of the size and gender of the control group on the 
ufTDI quantification of individual patients with cFE. 
 
2. Methods and Participants 
2.1. Participants 
A group of 48 patients [26 males with mean age 31.4 (SD: 11.5), 22 females with 
mean age 29.1 (SD: 9.2)] diagnosed with MRI-negative cryptogenic focal epilepsy (cFE) was 
investigated. 20 of those patients had a clinically clearly defined epileptogenic zone and 
were used for further analyses. All patients had conventional structural MRI at 3T using a 
specific epilepsy protocol, including high resolution 3D T1 and 3D FLAIR images, coronal 
FLAIR T2 and inversion recovery T1 images, not showing any structural epileptogenic 
lesions. All patients underwent a series of neurological examinations including scalp EEG 
and Video Monitoring, FDG-PET, ictal SPECT and in some cases invasive intracranial EEG.  
60 healthy controls (CTR) with no previous history of neurological or psychiatric 
disease were included in the healthy population (HP) group [mean age of 28.7 years (SD: 
7.1), 30 males and 30 females].  
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The University of Munich Ethics Committee approved the study and all participants 
gave written and informed consent.  
 
2.2. DTI acquisition and pre-processing 
All participants had additional DTI data acquisition on a 3T GE Signa HDx Scanner 
with an 8-channel head coil using 64 diffusion-weighted directions, a b-value of 1000 
s/mm², 60 axial slices with 2.4 mm slice thickness, a 96x96 in-plane matrix with a 220mm 
field of view, TR 16000 ms, TE 90.2 ms, flip angle 90° and parallel imaging with a SENSE 
factor of 2. 
DTI-images were resampled to isotropic 1mm voxel size and corrected for 
movement and distortions caused by eddy currents using eddy-correct function in FSL 4.1.9 
software (http://fsl.fmrib.ox.ac.uk).  Skull-stripped, realigned images were processed with 
FSL dtifit to create fractional anisotropy (FA) maps. 
 
2.4. Streamline Tractography and U-fiber selection 
Deterministic streamline tracking seeding from every voxel within the brain was 
performed using the Diffusion Toolkit 0.6.2.1 (http://trackvis.org/). This was based on 2nd-
order Runge Kutta propagation algorithm with an angular threshold of 35°. The termination 
criteria of the tracking were either exiting the brain or when the FA value in a voxel was 
<0.1. The streamlines were then visually analyzed in TrackVis 0.5.2.1 (http://trackvis.org/) 
to check for erroneous tracking.  
The population of U-fibers was selected from the whole brain tracking data using the 
command line tool track_vis with the following selection parameters: length 20-60mm, 
curvature 2-10 and U-factor 0.6-1 (more information available in the help command in 
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track_vis, as part of TrackVis). These were then used to create U-fiber track density images 
(ufTDI) (Goc et al., submitted), where the value at each pixel represents the number of U-
fibers passing through it.  
 
 
2.5. Spatial Normalization 
The FA maps were spatially normalized to the FMRIB58_FA template in MNI space 
using SPM5 software (http://www.fil.ion.ucl.ac.uk/) with the following settings: Source 
Image Smoothing 5mm, Non-linear Frequency cut-off 12mm, non-linear Regularization 0.1, 
non-linear iterations 128. The determined transformation from individual DTI space to MNI 
template space was then applied to ufTDI. 
 
2.6. Voxel-wise Statistical Analysis 
Spatially normalized ufTDI of an individual brain was used for the voxel-wise 
statistical analysis based on the method described elsewhere (Vollmar et al., in prep; Goc et 
al., submitted; Henson, 2006). In short, for each patient ufTDI difference images are 
calculated by subtracting each CTR ufTDI from a patient’s ufTDI. These difference images 
are then analyzed using a one-sample t-test for each individual cFE patient. This was also 
repeated for each individual CTR in the same way. 
Additionally, to limit the false-positive results, a U-fiber-specific mask was created 
by averaging the spatially normalized ufTDIs of all participants. This was then smoothed by 
FWHM 8, thresholded at 3. and binarised. Using the FSL Atlas tool, subcortical structures 
(brainstem, caudate, putamen, pallidum, thalamus and lateral ventricles) and cerebellum 
were subtracted from the mask.  
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Four analyses were performed. 1) We investigated the effects of the size of the HP 
group on the quantification results on ufTDI in 20 individual cFE patients, in which case the 
number included in the HP group varied: 20, 30, 40, 50 and 60 HP. Each individual CTR was 
also analyzed against the whole group of HP in the same way as the 20 cFE patients. 2) In 
the second part of the study, we investigated the importance of “cleaned” up HP group, 
where outliers were removed, in comparison to the 60HP group. The average and standard 
deviation (SD) of t-scores of individual CTR from the 60HP-quantification were calculated 
and CTR participants that had t-score higher than the average plus one standard deviation 
were excluded with the aim of selecting CTR with a normal distribution and no outliers. The 
re-selected “cleaned-up” HP group consisted of 49 healthy controls. 3) Additionally, a two 
sample t-test was performed comparing the male and female G-HP groups. 4) The last part 
of the study evaluated the effects of using a gender-specific healthy population (G-HP) on 
the quantification including 30 HP each for a male and female G-HP.  
The resulting clusters of decreased ufTDI were analyzed at the threshold of p<0.001 
after family wise error (FWE) correction for multiple comparisons of and with a spatial 
extent threshold of >5000 voxels.  
 
3. Results 
3.1. Size of the Control Group 
The analysis was performed based on a comparison of 20 cFE patients against 
groups of controls of: 20, 30, 40, 50 and 60 HP.  
The average t-score of the primary clusters gradually increased with the increase in 
the size of the control group showing a high R2 value for a non-linear regression model 
(R2=0.993; Fig. 1). With the increasing HP group, the distinction between CTR and cFE 
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becomes stronger and the t-scores are higher for cFE than CTR. While the smallest HP of 20 
resulted in similar t-scores in cFE and CTR (p=0.09), increasing the number of HP allowed 
for a better separation of cFE and CTR, (30HP: p=2.1410-5; 40HP: p= 1.0010-4; 50HP: p= 
1.0010-4; 60HP: p= 4.0910-5; Fig. 1).  
The resulting peak t-score increased with the increasing number of HP, therefore the 
threshold had to be adjusted accordingly. This implies that the clusters cannot be compared 
based on t-score alone. To be able to compare them, cluster weight was calculated by 
multiplying the t-score and the cluster size for each individual patient against 30HP at p< 
0.001 and extend threshold of 5cm3. The threshold was then adjusted for each analysis to 
match the cluster weight of the primary cluster of the same patient at 30HP.   
Importantly, the primary clusters of every cFE patient remained at the same location 
for all variations of HP, therefore the size of the control group did not fundamentally affect 
the primary results. Additionally, as the size of the HP group increases, the volume of 
additional, false-positive clusters decreased, providing more “cleaned up” results (Fig. 1).  
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Figure 1 Graphical representation of peak t-scores in cFE group against HP groups of different sizes. 
The ufTDI were quantified for 20 cFE patients. Each box and whisker plot represents the peak t-score of the 
primary cluster in patients for a given HP group. The thick black line represents polynomial regression of the 
average t-score per each HP group (R2= 0.993). Underneath the graph are two examples showing the changes 
in cluster volume in glass brain, as the number of controls increases in the HP group.   
 
3.2. Re-selected HP Group 
The peak t-scores of ufTDI reductions seen in individual CTR differed significantly 
between 60HP and 49HP groups (p=0.0047) with the average t-score of 17.18 and 15.84, 
respectively (Fig. 2). On the other hand, the peak t-scores for cFE were similar in both 60HP 
and 49HP groups (p=0.44) with average t-score of 20.26 and 19.66, respectively. 
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Consequently, the re-selected 49 HP group did further strengthen the separation between 
CTR and cFE (p=5.2510-6) and decreased the cluster volume of secondary and tertiary 
clusters by 8%. In some patients, the quantification using 49 HP group resulted in new 
additional clusters (Fig. 2, Patient 1), which could indicate regions implicated in epilepsy 
that were previously “hidden” in quantification based on a larger, but less homogenous HP 
group. 
 
Figure 2 ufTDI quantification of CTR and cFE against re-selected HP group. Box and whisker plot 
showing t-scores of primary clusters for CTR and cFE against two HP groups: 60HP and 49HP. The latter HP 
group is a re-selected group based on the ufTDI quantification of CTR against 60HP where mild outliers were 
excluded. A two-tailed two-sampled student’s t-test was performed showing a significant difference between 
CTR and cFE in 60HP (p=1.37x10-5) and 49hp (p=5.25x10-6). On the right are two examples of cFE patients 
using re-selected group quantification showing redistribution of t-scores within the clusters are reduced 
cluster volume.  
 
3.3. Structural differences between male and female brains 
A two sample t-test was performed comparing male and female G-HP groups. The 
differences were minor (at p<0.05 uncorrected). Females showed higher U-fiber track 
density in the superior frontal gyrus, posterior temporal neocortex and left occipital lobe. 
Males showed increased ufTDI in inferior central region above the Sylvian fissure (Fig. 3). 
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Figure 3. Differences in ufTDI between female and male control population. Results of two sample t-test 
where female and male healthy brains were compared. Increased ufTDI seen in A) female brains compared to 
male, B) male brains compared to female at p<0.05, uncorrected.  
 
 3.4. Gender-specific quantification 
The ufTDI of all 48 cFE patients were individually quantified using mixed HP group 
of 30 healthy controls and compared to quantification using 30 gender-matched controls. 
The primary clusters in all cFE patients were located in the same region (Fig. 4), but the 
peak t-scores were lower when using the G-HP group. The overall volume of all the clusters 
in both male and female groups for cFE and CTR groups decreased with a higher reduction 
in cFE compared to CTR (Table 1.) 
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Figure 4 Glass-brains of patients comparing mixed HP to G-HP quantification. Shows 3 male and 3 
female cFE patients at FWE p<0.001 and extent threshold of 5cm3. The primary clusters remain in the same 
location when using G-HP group, whereas the additional clusters either disappear or become smaller. In G-HP-
based quantification, the t-scores within the primary cluster are redistributed giving a higher contrast within 
the cluster and increased specificity.  
 
 
Average no. of clusters 
Average volume of all 
clusters (cm3) average difference 
in volume of all 
clusters (± SD) Mixed HP 
Gender-
matched HP 
Mixed HP 
Gender-
matched HP 
P
at
ie
n
ts
 
Male 2.8 2.7 137.0 120.0 -17.0% (±15.0%) 
Female 3.1 2.8 123.8 101.2 -21.5% (± 25.3%) 
C
o
n
tr
o
ls
 
Male 2.9 2.8 69.6 65.4 -1.3% (±25.0%) 
Female 2.3 2.1 68.6 55.3 -24.8% (±30.6%) 
Table 1 Cluster volume differences between mixed HP group and G-HP group.  
 
4. Discussion 
It is common understanding that the control population for statistical analysis in 
neuroimaging should resemble the tested population in all aspects, except for what is being 
tested, in this case the diagnosis of cryptogenic focal epilepsy (cFE). Here, we showed that 
careful selection of the control population might not fundamentally change the results, but 
it might reduce the amount of noise and additional clusters.  
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How many healthy participants are needed for such a statistical analysis? We 
evaluated the effects of increasing number of HP and there were two main effects. First, the 
number of additional and false-positive clusters has decreased. Second, with an increase in 
control population statistical significance in the form of t-score also increases. In a single-
subject study, increasing the number of controls increases the statistical significance of the 
method. The highest number of HP used in this study was 60 and the plateau of the peak t-
score of the primary cluster was not yet reached, which could indicate that an even larger 
HP group would still result in higher t-scores.  
Healthy participants in the HP groups were randomized. By chance the distribution 
of the t-scores of CTR in 30HP was close to normal, but other groups showed much higher 
variability (Fig. 1). Obviously by introducing additional CTR with an unusual distribution of 
Fibers. For this reason, we decided to investigate a “cleaner” HP group, where we excluded 
11 healthy participants from the 60HP group with the highest individual variability of their 
U-fiber density. The results showed a stronger separation between CTR and cFE groups, 
which is clinically more relevant. This shows that the t-score alone is not the determining 
factor of what an effective method is. The reselected HP group of 49 participants had a 
more homogenous distribution and a better separation between CTR and cFE, thus showing 
that the size of the group alone is not enough and does not outweigh the importance of 
homogenous control population.  
 
Similarly, using gender-matched HP group also resulted in decreased average t-score 
for both CTR and cFE and it also improved the separation of CTR from cFE patients and 
reduced the total cluster volume in the form of additional clusters. We have shown that 
absolute t-scores are not comparable and other factors are equally, if not more, important, 
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such as cluster size, cluster weight, distribution of the t-scores within a cluster, number of 
clusters per subject, etc.  
While visually inspecting the results of the quantification for each subject, we 
noticed certain clusters of minor significance that appeared in the same region in patients 
of the same gender, e.g. a cluster in right posterior temporal lobe was often seen in male 
patients, when compared to the mixed HP and often this was no longer present when using 
the gender-matched control population. To counteract the possibly-artefactual and 
potentially-confusing clusters, we decided to investigate the effects of gender-matched HP 
group. We performed a two sample t-test comparing healthy male and female brains and 
found increases in ufTDI in regions previously reported, e.g. females showed increased 
volume in the cingulate cortex (Chen et al., 2007).  
We found that in gender-matched ufTDI quantification, there is an overall decrease 
in cluster volume, primarily of the additional clusters, in patients by 17-21.5%. Introducing 
gender-matched HP groups “cleaned” up the results, making it easier for clinicians to 
interpret results, even though this did not fundamentally alter the results or did not 
increase the statistical value. Additionally, the distribution of the t-scores, as seen in the 
glass brain, shows a greater contrast, thus making it clearer to determine where the peak 
isolated within a large primary cluster.  
An optimal composition of the control population is particularly important for 
single-subject studies like this. Careful selection of control population allows for improved 
results, while the fundamental, primary cluster remains at the same location. In patients, it 
can reduce the volume of additional or false-positive clusters in the range of 17-21.5% and 
improve the specificity of the method.  
 
Chapter 5. Gender and Controls   108 
           
 
5. Acknowledgements 
This study was supported by the Friedrich-Baur-Stiftung and the Herta-Riehr Stiftung.  
 
  
Chapter 5. Gender and Controls   109 
           
 
6. References 
Brun, C.C., Leporé, N., Luders, E., Chou, Y.-Y., Madsen, S.K., Toga, A.W., Thompson, P.M., 2009. 
Sex differences in brain structure in auditory and cingulate regions. Neuroreport 20, 
930–5. doi:10.1097/WNR.0b013e32832c5e65 
Button, K.S., Ioannidis, J.P.A., Mokrysz, C., Nosek, B.A., Flint, J., Robinson, E.S.J., Munafò, M.R., 
2013. Power failure: why small sample size undermines the reliability of neuroscience. 
Nat. Rev. Neurosci. 14, 365–76. 
Chen, X., Sachdev, P.S., Wen, W., Anstey, K.J., 2007. Sex differences in regional gray matter in 
healthy individuals aged 44-48 years: a voxel-based morphometric study. Neuroimage 
36, 691–9. doi:10.1016/j.neuroimage.2007.03.063 
Greene, D.J., Black, K.J., Schlaggar, B.L., 2016. Considerations for MRI study design and 
implementation in pediatric and clinical populations. Dev. Cogn. Neurosci. 18, 101–
112. doi:10.1016/j.dcn.2015.12.005.CONSIDERATIONS 
Grimes, D. a., Schulz, K.F., 2005. Compared to what? Finding controls for case-control 
studies. Lancet 365, 1429–1433. doi:10.1016/S0140-6736(05)66379-9 
Henson, R., 2006. Comparing a single patient versus a group of controls (and SPM) 1–5. 
Rosenow, F., Lüders, H., 2001. Presurgical evaluation of epilepsy. Brain 124, 1683–700. 
doi:10.4103/1817-1745.40593 
Sacher, J., Neumann, J., Okon-Singer, H., Gotowiec, S., Villringer, A., 2013. Sexual dimorphism 
in the human brain: Evidence from neuroimaging. Magn. Reson. Imaging 31, 366–375. 
doi:10.1016/j.mri.2012.06.007 
Schulz, K.F., Grimes, D. a., 2002. Case-control studies: research in reverse. Lancet 359, 431–
434. doi:10.1016/S0140-6736(02)07605-5 
Chapter 6. General Discussion   110 
           
 
CHAPTER 6. GENERAL DISCUSSION 
6.1. OVERVIEW 
Patients with pharmacoresistant focal epilepsy may benefit from resective surgery, 
in which the epileptogenic zone (EZ) is removed. Typically, patients undergo a series of 
neurological tests, including scalp EEG, MRI and in some cases ictal SPECT or PET studies 
and invasive EEG recordings. In cryptogenic focal epilepsy (cFE) conventional MRI does not 
show any structural lesion and the localization of the EZ is often more challenging. 
Imprecise localization of the EZ in these patients can result in poorer surgical outcome. For 
this reason, there have been a number of studies investigating alternative MRI approaches 
that would improve the localization of the EZ, starting with voxel based morphometry using 
T1 (Huppertz et al., 2005) or T2 FLAIR images (Focke et al., 2009) to FA and MD quantitative 
analyses (Eriksson et al., 2001; Rugg-Gunn et al., 2001; Thivard et al., 2011).  
In focal epilepsy, one of the most commonly occurring pathologies is focal cortical 
dysplasia (FCD), whose histopathological characteristics include blurring of the grey and 
white matter border and cytoarchitectural alterations (Blümcke et al., 2011). For that 
reason, I focused on the role of short association fibers, called U-fibers. They are located 
directly at the border between grey and white matter and might be affected by FCD.  
The clinical features of cFE are hugely variable between different patients, thus 
preventing conventional group comparisons. Instead, each patient needs to be analyzed 
individually. The new diagnostic method for cryptogenic focal epilepsy introduced and 
discussed throughout this thesis, uses a tractography mapping approach of track density 
images (TDI) (Calamante et al., 2010). A density image of U-fibers can be calculated by 
selecting U-fibers from whole brain streamline tracking data of an individual, thus creating 
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a U-fiber track density image (ufTDI), for every participant. The ufTDI were used to 
calculate difference images between individual patients with cFE and a group of healthy 
participants. These difference images were then used in one-sample t-test. This statistical 
analysis approach, proposed by Henson increases the sensitivity and allows a single-subject 
statistical tests (Henson, 2006).  
DTI-based research commonly uses either FA or MD maps, therefore the first step 
was to compare the effectiveness of ufTDI quantification against the conventionally used 
DTI-based measures FA and MD in a sample of cFE patients (n=10) with a clear clinical 
localization of the EZ (see Chapter 2. From FA to U-). The ufTDI quantification successfully 
localized the EZ in 8 out of 10 patients, whereas the FA quantification correctly localized EZ 
in only 2 out of 10 patients and MD in only one patient, which is similar to the low yield in 
previously reported studies for both FA and MD (Rugg-Gunn et al., 2001; Thivard et al., 
2011). The alterations in ufTDI showed circumscribed and confined changes, whereas FA 
and MD maps were often unspecific and widespread. This indicated that our ufTDI 
approach is more sensitive and specific than the conventional DTI measures. The additional 
step of performing streamline tracking and selecting U-fibers suggests that there might be 
specific microstructural alterations at the grey-white matter border, which interfere with 
the simple tracking algorithm. 
Quantifying ufTDI proved to perform better than FA or MD and in a more extensive 
analysis, which included 22 patients, the reductions in ufTDI were more closely analyzed 
and compared to the clinical data (see Chapter 3. On The Clinical Side). Each patient with 
cFE showed different extent, severity and pathology of the disorder and this diversity is 
reflected in the observed clusters of reduced U-fiber track density. Results showed a wide 
range of clusters ranging from a single, small and circumscribed cluster to multiple or 
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larger clusters extending to both hemispheres. One or more cluster was detected in 95% of 
all patients and 75% of all clusters correlated with the clinical data, such as EEG recording, 
PET and/or ictal SPECT. This sensitivity and specificity is higher than any other reported 
neuroimaging method in cryptogenic focal epilepsy (Thivard et al., 2011). The remaining 
clusters could mean a number of things as mentioned in Chapter 3. However, most likely 
some of the false-positive clusters are unrelated to epilepsy and reflect individual 
anatomical variations.  
The false-positive clusters could be due to e.g. individual subject variability or 
inadequately selected parameters in the pre-processing pipeline. Therefore, the next step 
involved the optimization of the ufTDI quantification pipeline to further enhance the 
specificity of the method and to reduce the amount epilepsy-unrelated clusters (see Chapter 
4. Effects of Pre-processing). I evaluated different steps within the pipeline starting with the 
parameters for spatial normalization to tracking algorithms and using a U-fiber-specific 
mask. Here, the clusters were described in more detail, i.e. number of clusters per patient, 
the t-score of each cluster and the cluster weight. Based on the additional information, I was 
able to suggest a ranking of clusters: primary, secondary and tertiary to reflect the 
significance of the cluster in relation to the clinical data. The primary cluster represents the 
highest cluster weight and was further verified by correlation to the clinical data. 
In neuroimaging, one of the most important pre-processing step is spatial 
normalization. It allows for the comparison between subjects by aligning each brain to a 
common space, e.g. MNI-space. There is a variety of software options and algorithms that 
are able to perform this spatial normalization. We have compared two commonly used 
software packages: SPM and ANTs, where I analyzed the default (SPMd) and optimized 
(SPMo) parameter settings in SPM and optimized settings in ANTs. The results showed that 
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both SPMo and ANTs performed better than SPMd with a higher specificity and fewer false-
positive findings. However, the type of normalization did not fundamentally influence the 
outcome of the quantification, i.e. the primary cluster remained present and at the same 
location in all three spatial normalization procedures further supporting the initial 
hypothesis that regional U-fibers are affected in cFE patients.  
A U-fiber-specific mask was created, where an averaged and binarised density map 
of U-fibers was generated. Conventionally, a whole brain mask in MNI space is used for 
analyses in SPM. However, when using the whole brain mask, clusters of reduced “U-fibers” 
were observed in areas where U-fibers are not expected to be present. Therefore, a U-fiber-
specific mask allows for a focused analysis restricted to the regions of the brain that we are 
interested in. Using this mask resulted in fewer secondary and tertiary false-positive 
clusters by 31.6%, whilst leaving the primary cluster at the same location with the same 
statistical significance in all patients.    
During a pilot study, the number of healthy participants was only 18, but even then 
the ufTDI quantification already showed promising results. The next study included 30 
healthy participants, which resulted in fewer additional clusters. This confirmed that the 
role of the control group has a greater impact on the statistical analysis. Therefore, Chapter 
5 explores the effects of control population on the results of the ufTDI quantification. In that 
study, I investigated two main aspects: 1) the effects of the size of the healthy population 
and 2) gender-matching of the population (see Chapter 5. Gender and Controls).  
Increasing the size of the healthy population strengthens the statistics, improves the 
sensitivity of the method and reduces the number of false-positive clusters. The biggest 
healthy population group that was analyzed in Chapter 5 included 60 healthy participants 
and the average t-score of the primary clusters among cFE patients was the highest. 
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However, a remaining question was, which is more important: quantity or quality of the 
healthy population? To answer that question, I re-selected healthy participants from the 
pool of all controls available (n=60) based on the variability within group, thus excluding 11 
participants as mild outliers. The comparison of the ufTDI quantification of the cFE patients 
based on “cleaner” group and “larger” group revealed fewer false-positive clusters and 
more focused redistribution of the t-scores within the primary cluster in cFE patients when 
using “cleaner” healthy population. More importantly, the “cleaner” group showed 
strengthened separation between healthy controls and cFE patients, which is clinically 
more meaningful.  Thus, in this case “quality” seems to be more effective than “quantity”.  
As mentioned earlier, some of the false-positive clusters are possibly caused by 
individual variability and this might include gender differences as well. Gender differences 
have been extensively investigated over the last decade (Sacher et al., 2013) and studies 
have found many functional and structural dissimilarities. Chapter 5 explains in more detail 
that using a gender-matched healthy population further reduces the number of false-
positive clusters by 17-21.5% without changing the location of the primary cluster, thus 
improving the specificity of the method.  
 In summary, quantifying ufTDI in cFE patients proves to be a sensitive, specific and 
robust method that localizes the EZ reliably in the majority of cases. Improving and 
optimizing individual steps within the pre-processing and processing pipeline shows to 
have small effects, but when combined they have considerably reduced false-positive 
clusters, increased the t-score of the primary cluster and strengthened the separation 
between healthy population and cFE patients. Thus, improving sensitivity and specificity to 
a level not achieved by any other diagnostic method to localize the EZ.  
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6.2.  CLINICAL APPLICATION 
The ufTDI quantification for localization of the epileptogenic zone in cFE is still an 
experimental method, nonetheless we are already implementing it routinely in the Epilepsy 
Centre at the University of Munich Hospital. Currently, we quantify ufTDI in all incoming 
patients with cryptogenic focal epilepsy before the implantation of the intracranial 
electrodes. This allows the neurologists to include this information in the planning of the 
electrode placement. In some cases, the ufTDI quantification showed reductions in regions 
that were not clinically suspected prior to invasive EEG recordings and often the 
intracranial electrodes later confirmed that these regions were also involved in seizure 
generation.  
So far I performed the quantification using optimized spatial normalization, U-fiber 
specific mask and gender-matched control group on 67 patients of which 18 had 
implantation of electrodes and 10 had resective surgery. Many other patients are currently 
awaiting implantation of electrodes or resections. 
Few patients showed widespread bilateral reductions of U-fiber density (see Fig. 5, 
Chapter 3) and bilateral seizure onset was then confirmed using intracranial electrodes. 
These patients are not candidates for resective surgery and ufTDI quantification could 
potentially be used as an exclusion test in the future. This may prevent unnecessary risks of 
surgery and invasive EEG recordings.  
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SUMMARY POINTS 
 
• U-fiber Track Density Images (ufTDI) reflect the number of U-fibers per voxel in an 
individual brain 
• ufTDI reflect different microstructural tissue properties than conventional FA or MD 
maps 
• ufTDI quantification can localize mild architectural changes in cryptogenic epilepsy 
with higher specificity and sensitivity than FA or MD  
• FA and MD quantification shows widespread and unspecific alterations 
• 95% of the patients with no structural lesion in conventional 3T MRI showed 
reductions in ufTDI 
• 75% of all clusters observed in cFE patients correlated with clinical data 
• Optimized settings of spatial normalization improve the statistical significance of the 
ufTDI quantification 
• A U-fiber-specific mask reduces the volume of false-positive clusters by 31.6%.  
• Both, increasing the size and removing outliers from the healthy population 
improves the statistical significance of the ufTDI quantification and strengthens the 
separation of healthy controls and cFE patients 
• Using a gender-specific control population reduces the volume of false-positive 
clusters by 17-21.5% 
• Quantification of ufTDI is already routinely used for guidance of electrode 
implantation in the Epilepsy Centre at the University of Munich Hospital  
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